jrvr-202103310001620459--12-31falseQ12021us-gaap:AccountingStandardsUpdate201613Member00016204592021-01-012021-03-31xbrli:shares00016204592021-04-30iso4217:USD0001620459us-gaap:DebtSecuritiesMember2021-03-3100016204592020-12-3100016204592021-03-31iso4217:USDxbrli:shares00016204592020-01-012020-03-310001620459us-gaap:CommonStockMember2020-12-310001620459us-gaap:PreferredStockMember2020-12-310001620459us-gaap:AdditionalPaidInCapitalMember2020-12-310001620459us-gaap:RetainedEarningsMember2020-12-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001620459us-gaap:RetainedEarningsMember2021-01-012021-03-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001620459us-gaap:CommonStockMember2021-01-012021-03-310001620459us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001620459us-gaap:CommonStockMember2021-03-310001620459us-gaap:PreferredStockMember2021-03-310001620459us-gaap:AdditionalPaidInCapitalMember2021-03-310001620459us-gaap:RetainedEarningsMember2021-03-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001620459us-gaap:CommonStockMember2019-12-310001620459us-gaap:PreferredStockMember2019-12-310001620459us-gaap:AdditionalPaidInCapitalMember2019-12-310001620459us-gaap:RetainedEarningsMember2019-12-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-3100016204592019-12-310001620459us-gaap:RetainedEarningsMember2020-01-012020-03-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001620459us-gaap:CommonStockMember2020-01-012020-03-310001620459us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001620459us-gaap:RetainedEarningsMemberus-gaap:AccountingStandardsUpdate201905Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001620459us-gaap:AccountingStandardsUpdate201905Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-3100016204592019-01-012019-12-310001620459us-gaap:RetainedEarningsMemberus-gaap:AccountingStandardsUpdate201613Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001620459us-gaap:AccountingStandardsUpdate201613Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001620459us-gaap:CommonStockMember2020-03-310001620459us-gaap:PreferredStockMember2020-03-310001620459us-gaap:AdditionalPaidInCapitalMember2020-03-310001620459us-gaap:RetainedEarningsMember2020-03-310001620459us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-3100016204592020-03-31jrvr:company0001620459country:US2021-03-310001620459country:BM2021-03-310001620459jrvr:ExcessAndSurplusLinesMember2021-01-012021-03-31xbrli:pure0001620459us-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMember2021-03-310001620459us-gaap:CorporateDebtSecuritiesMember2021-03-310001620459us-gaap:CommercialMortgageBackedSecuritiesMember2021-03-310001620459us-gaap:USTreasuryAndGovernmentMember2021-03-310001620459us-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMember2020-12-310001620459us-gaap:CorporateDebtSecuritiesMember2020-12-310001620459us-gaap:CommercialMortgageBackedSecuritiesMember2020-12-310001620459us-gaap:USTreasuryAndGovernmentMember2020-12-310001620459us-gaap:DebtSecuritiesMember2020-12-31jrvr:issuer0001620459jrvr:StandardPoorsBBBorBetterRatingMemberus-gaap:DebtSecuritiesMember2021-03-310001620459jrvr:StandardPoorsBelowBBBRatingMember2021-03-310001620459us-gaap:AccountingStandardsUpdate201905Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-01-010001620459us-gaap:RetainedEarningsMemberus-gaap:AccountingStandardsUpdate201905Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-01-010001620459us-gaap:LoanParticipationsAndAssignmentsMember2021-01-012021-03-310001620459us-gaap:LoanParticipationsAndAssignmentsMember2020-01-012020-03-310001620459jrvr:RenewableEnergyLlcsMember2021-03-310001620459jrvr:RenewableEnergyLlcsMember2020-12-310001620459jrvr:RenewableEnergyLlcsMember2021-01-012021-03-310001620459jrvr:RenewableEnergyLlcsMember2020-01-012020-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMember2021-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMember2020-12-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMember2021-01-012021-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMember2020-01-012020-03-310001620459srt:PartnershipInterestMember2021-03-310001620459srt:PartnershipInterestMember2020-12-310001620459srt:PartnershipInterestMember2021-01-012021-03-310001620459srt:PartnershipInterestMember2020-01-012020-03-310001620459jrvr:BankHoldingCompaniesMember2021-03-310001620459jrvr:BankHoldingCompaniesMember2020-12-310001620459jrvr:BankHoldingCompaniesMember2021-01-012021-03-310001620459jrvr:BankHoldingCompaniesMember2020-01-012020-03-310001620459jrvr:InvestmentInLlcMemberus-gaap:CorporateAndOtherMembersrt:MinimumMember2021-03-310001620459srt:MaximumMemberjrvr:InvestmentInLlcMemberus-gaap:CorporateAndOtherMember2021-03-310001620459jrvr:InvestmentInLlcMemberus-gaap:CorporateAndOtherMember2021-01-012021-03-310001620459jrvr:InvestmentInLlcMemberus-gaap:CorporateAndOtherMember2020-01-012020-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMemberjrvr:ExcessAndSurplusLinesMember2021-01-012021-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMemberjrvr:ExcessAndSurplusLinesMember2020-01-012020-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMemberus-gaap:CorporateAndOtherMember2021-01-012021-03-310001620459jrvr:RenewableEnergyBridgeFinancingNotesMemberus-gaap:CorporateAndOtherMember2020-01-012020-03-310001620459us-gaap:CorporateAndOtherMembersrt:PartnershipInterestMember2021-03-310001620459us-gaap:CorporateAndOtherMembersrt:PartnershipInterestMember2021-01-012021-03-310001620459us-gaap:CorporateAndOtherMembersrt:PartnershipInterestMember2020-01-012020-03-310001620459jrvr:ExcessAndSurplusLinesMembersrt:PartnershipInterestMember2021-03-310001620459jrvr:ExcessAndSurplusLinesMembersrt:PartnershipInterestMember2021-01-012021-03-310001620459jrvr:ExcessAndSurplusLinesMembersrt:PartnershipInterestMember2020-01-012020-03-310001620459us-gaap:CorporateAndOtherMemberjrvr:InvestmentInBankHoldingCompanyMember2021-03-310001620459us-gaap:CorporateAndOtherMemberjrvr:BankHoldingCompaniesMember2020-01-012020-03-310001620459us-gaap:CorporateAndOtherMemberjrvr:BankHoldingCompaniesMember2021-01-012021-03-310001620459jrvr:BankHoldingCompanyMember2021-03-310001620459jrvr:JamesRiverGroupIncMember2007-12-110001620459us-gaap:TrademarksMember2021-03-310001620459us-gaap:TrademarksMember2020-12-310001620459us-gaap:LicensingAgreementsMember2021-03-310001620459us-gaap:LicensingAgreementsMember2020-12-310001620459jrvr:BrokerRelationshipsMember2021-01-012021-03-310001620459jrvr:BrokerRelationshipsMember2021-03-310001620459jrvr:BrokerRelationshipsMember2020-12-310001620459jrvr:StockOptionsAndRestrictedStockUnitsRsuMember2021-01-012021-03-310001620459jrvr:StockOptionsAndRestrictedStockUnitsRsuMember2020-01-012020-03-310001620459jrvr:ExcessAndSurplusLinesMemberjrvr:CommercialAutoBusinessMember2021-01-012021-03-310001620459jrvr:SpecialtyAdmittedInsuranceMember2021-01-012021-03-310001620459jrvr:CasualtyReinsuranceMember2021-01-012021-03-310001620459jrvr:ExcessAndSurplusLinesMember2020-01-012020-03-310001620459jrvr:SpecialtyAdmittedInsuranceMember2020-01-012020-03-310001620459jrvr:CasualtyReinsuranceMember2020-01-012020-03-31jrvr:credit_facility0001620459jrvr:JrgReinsuranceCompanyLtdMember2021-03-310001620459jrvr:LetterOfCredit75MillionMemberjrvr:JrgReinsuranceCompanyLtdMember2021-03-310001620459jrvr:A2013FacilityMemberjrvr:JrgReinsuranceCompanyLtdMember2021-03-310001620459jrvr:JrgReinsuranceCompanyLtdMemberjrvr:A2017FacilityMember2021-03-310001620459jrvr:JrgReinsuranceCompanyLtdMemberjrvr:ThirdpartyReinsuredsMember2021-03-310001620459jrvr:RaiserMember2021-03-31jrvr:segment0001620459us-gaap:CorporateAndOtherMember2021-01-012021-03-310001620459jrvr:ExcessAndSurplusLinesMember2021-03-310001620459jrvr:SpecialtyAdmittedInsuranceMember2021-03-310001620459jrvr:CasualtyReinsuranceMember2021-03-310001620459us-gaap:CorporateAndOtherMember2021-03-310001620459us-gaap:CorporateAndOtherMember2020-01-012020-03-310001620459jrvr:ExcessAndSurplusLinesMember2020-03-310001620459jrvr:SpecialtyAdmittedInsuranceMember2020-03-310001620459jrvr:CasualtyReinsuranceMember2020-03-310001620459us-gaap:CorporateAndOtherMember2020-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMember2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-03-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMember2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DebtSecuritiesMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001620459us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-012021-03-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2020-01-012020-03-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001620459us-gaap:SecuritiesAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2020-03-31jrvr:bank_loan_participationjrvr:security0001620459us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310001620459us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-03-310001620459us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001620459us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001620459jrvr:A2013FacilityMemberus-gaap:UnsecuredDebtMember2021-03-310001620459jrvr:A2013FacilityMemberus-gaap:LineOfCreditMember2021-03-310001620459jrvr:A2013FacilityMember2020-01-012020-03-310001620459jrvr:JrgReinsuranceCompanyLtdMemberjrvr:A2017FacilityMemberus-gaap:UnsecuredDebtMember2021-03-310001620459jrvr:JrgReinsuranceCompanyLtdMemberjrvr:A2017FacilityMember2020-01-012020-03-3100016204592021-02-242021-02-2400016204592021-03-312021-03-3100016204592020-02-192020-02-1900016204592020-03-312020-03-310001620459us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001620459us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-03-310001620459us-gaap:RestrictedStockUnitsRSUMember2021-03-310001620459us-gaap:RestrictedStockUnitsRSUMember2020-12-310001620459jrvr:LongTermIncentivePlan2014Memberus-gaap:EmployeeStockOptionMember2021-03-310001620459jrvr:NonEmployeeDirectorIncentivePlan2014Memberus-gaap:EmployeeStockOptionMember2021-03-310001620459us-gaap:EmployeeStockOptionMember2020-12-310001620459us-gaap:EmployeeStockOptionMember2019-12-310001620459us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001620459us-gaap:EmployeeStockOptionMember2020-01-012020-03-310001620459us-gaap:EmployeeStockOptionMember2021-03-310001620459us-gaap:EmployeeStockOptionMember2020-03-310001620459us-gaap:RestrictedStockUnitsRSUMember2019-12-310001620459us-gaap:RestrictedStockUnitsRSUMember2020-03-310001620459jrvr:NonemployeeDirectorsMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001620459us-gaap:SubsequentEventMember2021-04-270001620459us-gaap:SubsequentEventMember2021-06-302021-06-300001620459us-gaap:SubsequentEventMember2021-06-142021-06-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| | | | | |
☒ | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 |
or
| | | | | |
☐ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______ to _______ |
Commission File Number: 001-36777
| | |
JAMES RIVER GROUP HOLDINGS, LTD. |
(Exact name of registrant as specified in its charter)
| | | | | | | | |
Bermuda | | 98-0585280 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
Wellesley House, 2nd Floor, 90 Pitts Bay Road, Pembroke HM08, Bermuda
(Address of principal executive offices)
(Zip Code)
(441) 278-4580
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | | | | |
Title of each class | Trading Symbol(s) | Names of each exchange on which registered |
Common Shares, par value $0.0002 per share | JRVR | | NASDAQ | Global Select Market | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Large accelerated filer | x | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No x
Number of shares of the registrant's common shares outstanding at April 30, 2021: 30,774,930
James River Group Holdings, Ltd.
Form 10-Q
Index
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q, or Quarterly Report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may be identified by the fact that they do not relate strictly to historical or current facts. You may identify forward-looking statements in this Quarterly Report by the use of words such as “anticipates,” “estimates,” “expects,” “intends,” “plans”, “seeks” and “believes,” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could.” These forward-looking statements include, among others, all statements relating to our future financial performance, our business prospects and strategy, anticipated financial position and financial strength ratings, liquidity and capital needs and other similar matters. These forward-looking statements are based on management’s current expectations and assumptions about future events, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict.
Our actual results may differ materially from those expressed in, or implied by, the forward-looking statements included in this Quarterly Report as a result of various factors, many of which are beyond our control, including, among others:
•the inherent uncertainty of estimating reserves and the possibility that incurred losses may be greater than our loss and loss adjustment expense reserves;
•inaccurate estimates and judgments in our risk management may expose us to greater risks than intended;
•downgrades in the financial strength rating of our regulated insurance subsidiaries may impact our ability to attract and retain insurance and reinsurance business that our subsidiaries write, our competitive position, and our financial condition;
•the potential loss of key members of our management team or key employees and our ability to attract and retain personnel;
•adverse economic factors resulting in the sale of fewer policies than expected or an increase in the frequency or severity of claims, or both;
•reliance on a select group of brokers and agents for a significant portion of our business and the impact of our potential failure to maintain, such relationships;
•reliance on a select group of customers for a significant portion of our business and the impact of our potential failure to maintain, or decision to terminate, such relationships;
•our ability to obtain reinsurance coverage at prices and on terms that allow us to transfer risk and adequately protect our Company against financial loss;
•losses resulting from reinsurance counterparties failing to pay us on reinsurance claims, insurance companies with whom we have a fronting arrangement failing to pay us for claims, or a former customer with whom we have an indemnification arrangement failing to perform their reimbursement obligations;
•inadequacy of premiums we charge to compensate us for our losses incurred;
•changes in laws or government regulation, including tax or insurance law and regulations;
•the ongoing effect of Public Law No. 115-97, informally titled the Tax Cuts and Jobs Act, which may have a significant effect on us including, among other things, by potentially increasing our tax rate, as well as on our shareholders;
•in the event we do not qualify for the insurance company exception to the passive foreign investment company (“PFIC”) rules and are therefore considered a PFIC, there could be material adverse tax consequences to an investor that is subject to U.S. federal income taxation;
•the Company or any of its foreign subsidiaries becoming subject to U.S. federal income taxation;
•a failure of any of the loss limitations or exclusions we utilize to shield us from unanticipated financial losses or legal exposures, or other liabilities;
•losses from catastrophic events, such as natural disasters and terrorist acts, which substantially exceed our expectations and/or exceed the amount of reinsurance we have purchased to protect us from such events;
•the effects of the COVID-19 pandemic and associated government actions on our operations and financial performance;
•potential effects on our business of emerging claim and coverage issues;
•exposure to credit risk, interest rate risk and other market risk in our investment portfolio;
•the potential impact of internal or external fraud, operational errors, systems malfunctions or cyber security incidents;
•our ability to manage our growth effectively;
•failure to maintain effective internal controls in accordance with Sarbanes-Oxley Act of 2002, as amended (“Sarbanes-Oxley”); and
•changes in our financial condition, regulations or other factors that may restrict our subsidiaries’ ability to pay us dividends.
Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those in the forward-looking statements, is contained in Part II, Item 1A "Risk Factors" in this Quarterly Report, and our filings with the U.S. Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021.
Forward-looking statements speak only as of the date of this Quarterly Report. Except as expressly required under federal securities laws and the rules and regulations of the SEC, we do not have any obligation, and do not undertake, to update any forward-looking statements to reflect events or circumstances arising after the date of this Quarterly Report, whether as a result of new information or future events or otherwise. You should not place undue reliance on the forward-looking statements included in this Quarterly Report or that may be made elsewhere from time to time by us, or on our behalf. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.
PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
JAMES RIVER GROUP HOLDINGS, LTD. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
| | | | | | | | | | | |
| (Unaudited) March 31, 2021 | | December 31, 2020 |
| (in thousands) |
Assets | | | |
Invested assets: | | | |
| | | |
Fixed maturity securities, available-for-sale, at fair value (amortized cost: 2021 – $1,755,733; 2020 – $1,690,890) | $ | 1,800,151 | | | $ | 1,783,642 | |
| | | |
Equity securities, at fair value (cost: 2021 – $81,855; 2020 – $81,698) | 90,877 | | | 88,975 | |
Bank loan participations, at fair value | 160,880 | | | 147,604 | |
Short-term investments | 51,198 | | | 130,289 | |
Other invested assets | 55,863 | | | 46,548 | |
Total invested assets | 2,158,969 | | | 2,197,058 | |
| | | |
Cash and cash equivalents | 183,491 | | | 162,260 | |
Restricted cash equivalents | 751,668 | | | 859,920 | |
Accrued investment income | 11,634 | | | 10,980 | |
Premiums receivable and agents’ balances, net | 391,982 | | | 369,577 | |
Reinsurance recoverable on unpaid losses, net | 878,732 | | | 805,684 | |
Reinsurance recoverable on paid losses | 42,566 | | | 46,118 | |
Prepaid reinsurance premiums | 273,116 | | | 243,741 | |
Deferred policy acquisition costs | 63,606 | | | 62,953 | |
Intangible assets, net | 36,311 | | | 36,402 | |
Goodwill | 181,831 | | | 181,831 | |
Other assets | 135,801 | | | 86,548 | |
Total assets | $ | 5,109,707 | | | $ | 5,063,072 | |
See accompanying notes.
JAMES RIVER GROUP HOLDINGS, LTD. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (continued)
| | | | | | | | | | | |
| (Unaudited) March 31, 2021 | | December 31, 2020 |
| (in thousands, except share amounts) |
Liabilities and Shareholders’ Equity | | | |
Liabilities: | | | |
Reserve for losses and loss adjustment expenses | $ | 2,413,846 | | | $ | 2,192,080 | |
Unearned premiums | 674,343 | | | 630,371 | |
Payables to reinsurers | 130,593 | | | 110,431 | |
Funds held | 751,668 | | | 859,920 | |
Senior debt | 262,300 | | | 262,300 | |
Junior subordinated debt | 104,055 | | | 104,055 | |
Accrued expenses | 52,351 | | | 55,989 | |
Other liabilities | 80,923 | | | 52,318 | |
Total liabilities | 4,470,079 | | | 4,267,464 | |
Commitments and contingent liabilities | — | | | — | |
Shareholders’ equity: | | | |
Common Shares – 2021 and 2020: $0.0002 par value; 200,000,000 shares authorized; 30,774,930 and 30,649,261 shares issued and outstanding, respectively | 6 | | | 6 | |
Preferred Shares – 2021 and 2020: $0.00125 par value; 20,000,000 shares authorized; no shares issued and outstanding | — | | | — | |
Additional paid-in capital | 663,987 | | | 664,476 | |
Retained (deficit) earnings | (63,576) | | | 49,227 | |
Accumulated other comprehensive income | 39,211 | | | 81,899 | |
Total shareholders’ equity | 639,628 | | | 795,608 | |
Total liabilities and shareholders’ equity | $ | 5,109,707 | | | $ | 5,063,072 | |
See accompanying notes.
JAMES RIVER GROUP HOLDINGS, LTD. AND SUBSIDIARIES
Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited)
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands, except share amounts) |
Revenues | | | | | | | |
Gross written premiums | | | | | $ | 373,255 | | | $ | 283,841 | |
Ceded written premiums | | | | | (198,656) | | | (149,187) | |
Net written premiums | | | | | 174,599 | | | 134,654 | |
Change in net unearned premiums | | | | | (14,006) | | | 11,264 | |
Net earned premiums | | | | | 160,593 | | | 145,918 | |
Net investment income | | | | | 15,089 | | | 20,836 | |
Net realized and unrealized gains (losses) on investments | | | | | 6,272 | | | (58,407) | |
Other income | | | | | 1,026 | | | 1,937 | |
Total revenues | | | | | 182,980 | | | 110,284 | |
Expenses | | | | | | | |
Losses and loss adjustment expenses | | | | | 273,500 | | | 96,856 | |
Other operating expenses | | | | | 47,381 | | | 51,621 | |
Other expenses | | | | | 621 | | | — | |
Interest expense | | | | | 2,216 | | | 2,876 | |
Amortization of intangible assets | | | | | 91 | | | 149 | |
Total expenses | | | | | 323,809 | | | 151,502 | |
Loss before taxes | | | | | (140,829) | | | (41,218) | |
Income tax benefit | | | | | (37,369) | | | (4,403) | |
Net loss | | | | | (103,460) | | | (36,815) | |
Other comprehensive loss: | | | | | | | |
Net unrealized losses, net of taxes of $(5,647) in 2021 and $(1,391) in 2020 | | | | | (42,688) | | | (3,919) | |
Total comprehensive loss | | | | | $ | (146,148) | | | $ | (40,734) | |
Per share data: | | | | | | | |
Basic loss per share | | | | | $ | (3.37) | | | $ | (1.21) | |
Diluted loss per share | | | | | $ | (3.37) | | | $ | (1.21) | |
Dividend declared per share | | | | | $ | 0.30 | | | $ | 0.30 | |
Weighted-average common shares outstanding: | | | | | | | |
Basic | | | | | 30,713,986 | | | 30,476,307 | |
Diluted | | | | | 30,713,986 | | | 30,476,307 | |
See accompanying notes.
JAMES RIVER GROUP HOLDINGS, LTD. AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Number of Common Shares Outstanding | | Common Shares (Par) | | Preferred Shares | | Additional Paid-in Capital | | Retained Earnings (Deficit) | | Accumulated Other Comprehensive Income | | Total |
| (in thousands, except share amounts) |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Balances at December 31, 2020 | 30,649,261 | | | $ | 6 | | | $ | — | | | $ | 664,476 | | | $ | 49,227 | | | $ | 81,899 | | | $ | 795,608 | |
Net loss | — | | | — | | | — | | | — | | | (103,460) | | | — | | | (103,460) | |
Other comprehensive loss | — | | | — | | | — | | | — | | | — | | | (42,688) | | | (42,688) | |
Dividends | — | | | — | | | — | | | — | | | (9,343) | | | — | | | (9,343) | |
Exercise of stock options | 16,471 | | | — | | | — | | | 159 | | | — | | | — | | | 159 | |
Vesting of RSUs | 109,198 | | | — | | | — | | | (2,553) | | | — | | | — | | | (2,553) | |
Compensation expense under share incentive plans | — | | | — | | | — | | | 1,905 | | | — | | | — | | | 1,905 | |
Balances at March 31, 2021 | 30,774,930 | | | $ | 6 | | | $ | — | | | $ | 663,987 | | | $ | (63,576) | | | $ | 39,211 | | | $ | 639,628 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Balances at December 31, 2019 | 30,424,391 | | | $ | 6 | | | $ | — | | | $ | 657,875 | | | $ | 89,586 | | | $ | 31,114 | | | $ | 778,581 | |
Net loss | — | | | — | | | — | | | — | | | (36,815) | | | — | | | (36,815) | |
Other comprehensive loss | — | | | — | | | — | | | — | | | — | | | (3,919) | | | (3,919) | |
Dividends | — | | | — | | | — | | | — | | | (9,267) | | | — | | | (9,267) | |
| | | | | | | | | | | | | |
Vesting of RSUs | 96,037 | | | — | | | — | | | (2,038) | | | — | | | — | | | (2,038) | |
Compensation expense under share incentive plans | — | | | — | | | — | | | 1,867 | | | — | | | — | | | 1,867 | |
Cumulative effect of fair value option election | — | | | — | | | — | | | — | | | (7,827) | | | — | | | (7,827) | |
Cumulative effect of adoption of ASU No. 2016-13 | — | | | — | | | | | — | | | (265) | | | — | | | (265) | |
Balances at March 31, 2020 | 30,520,428 | | | $ | 6 | | | $ | — | | | $ | 657,704 | | | $ | 35,412 | | | $ | 27,195 | | | $ | 720,317 | |
See accompanying notes.
JAMES RIVER GROUP HOLDINGS, LTD. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| (in thousands) |
Operating activities | | | |
Net cash used in operating activities (a) | $ | (81,005) | | | $ | (65,305) | |
Investing activities | | | |
Securities available-for-sale: | | | |
Purchases – fixed maturity securities | (171,178) | | | (182,205) | |
Sales – fixed maturity securities | 33,041 | | | 4,513 | |
Maturities and calls – fixed maturity securities | 73,530 | | | 34,861 | |
Purchases – equity securities | (4,305) | | | (7,435) | |
Sales – equity securities | 3,776 | | | 3,295 | |
Bank loan participations: | | | |
Purchases | (35,832) | | | (18,408) | |
Sales | 15,527 | | | 9,735 | |
Maturities | 11,190 | | | 13,220 | |
Other invested assets: | | | |
Purchases | (9,795) | | | (438) | |
Return of capital | 249 | | | 253 | |
Redemptions | — | | | 13,133 | |
Short-term investments, net | 79,091 | | | 85,867 | |
Securities receivable or payable, net | 10,694 | | | (5,770) | |
Purchases of property and equipment | — | | | (342) | |
Net cash provided by (used in) investing activities | 5,988 | | | (49,721) | |
Financing activities | | | |
Senior debt issuances | — | | | 119,000 | |
| | | |
Dividends paid | (9,610) | | | (9,468) | |
Issuance of common shares under equity incentive plans | 159 | | | — | |
Common share repurchases | (2,553) | | | (2,038) | |
| | | |
Net cash (used in) provided by financing activities | (12,004) | | | 107,494 | |
Change in cash, cash equivalents, and restricted cash equivalents | (87,021) | | | (7,532) | |
Cash, cash equivalents, and restricted cash equivalents at beginning of period | 1,022,180 | | | 1,406,076 | |
Cash, cash equivalents, and restricted cash equivalents at end of period | $ | 935,159 | | | $ | 1,398,544 | |
Supplemental information | | | |
Interest paid | $ | 2,482 | | | $ | 3,248 | |
| | | |
Restricted cash equivalents at beginning of period | $ | 859,920 | | | $ | 1,199,164 | |
Restricted cash equivalents at end of period | $ | 751,668 | | | $ | 1,107,321 | |
Change in restricted cash equivalents | $ | (108,252) | | | $ | (91,843) | |
(a) Cash used in operating activities for the three months ended March 31, 2021 and 2020 primarily reflect $108.3 million and $91.8 million, respectively, of restricted cash equivalents returned to a former insured, per the terms of a collateral trust (see Amounts Recoverable from an Indemnifying Party in Liquidity and Capital Resources). Excluding the reduction in the collateral funds, cash provided by operating activities was $27.2 million and $26.5 million for the three months ended March 31, 2021 and 2020, respectively.
See accompanying notes.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
1. Accounting Policies
Organization
James River Group Holdings, Ltd. (referred to as “JRG Holdings” or, with its subsidiaries, the “Company”) is an exempted holding company registered in Bermuda, organized for the purpose of acquiring and managing insurance and reinsurance entities.
The Company owns five insurance companies based in the United States (“U.S.”) focused on specialty insurance niches and two Bermuda-based reinsurance companies as described below:
•James River Group Holdings UK Limited (“James River UK”) is an insurance holding company formed in 2015 in the United Kingdom (“U.K.”). JRG Holdings contributed James River Group, Inc. (“James River Group”), a U.S. insurance holding company, to James River UK in 2015.
▪James River Group is a Delaware domiciled insurance holding company formed in 2002 which owns all of the Company’s U.S.-based subsidiaries, either directly or indirectly through one of its wholly-owned U.S. subsidiaries. James River Group oversees the Company’s U.S. insurance operations and maintains all of the outstanding debt in the U.S.
◦James River Insurance Company is an Ohio domiciled excess and surplus lines insurance company that, with its wholly-owned insurance subsidiary, James River Casualty Company, a Virginia domiciled company, is authorized to write business in every state and the District of Columbia.
◦Falls Lake National Insurance Company (“Falls Lake National”) is an Ohio domiciled insurance company which wholly owns Stonewood Insurance Company (“Stonewood Insurance”), a North Carolina domiciled company, and Falls Lake Fire and Casualty Company, a California domiciled company. Falls Lake National and its subsidiaries primarily write specialty admitted fronting and program business and individual risk workers' compensation insurance.
◦JRG Reinsurance Company Ltd. (“JRG Re”) was formed in 2007 and commenced operations in 2008. JRG Re, a Bermuda domiciled reinsurer, primarily provides non-catastrophe casualty reinsurance to U.S. third parties and, through December 31, 2017, to the Company’s U.S.-based insurance subsidiaries.
◦Carolina Re Ltd (“Carolina Re”) was formed in 2018 and as of January 1, 2018 provides reinsurance to the Company’s U.S.-based insurance subsidiaries. Carolina Re is also the cedent on a stop loss reinsurance treaty with JRG Re.
Basis of Presentation
The accompanying condensed consolidated financial statements and notes have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and do not contain all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements include the results of the Company and its subsidiaries from their respective dates of inception or acquisition, as applicable. Readers are urged to review the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for a more complete description of the Company’s business and accounting policies. In the opinion of management, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2020 was derived from the Company’s audited annual consolidated financial statements.
Intercompany transactions and balances have been eliminated.
Estimates and Assumptions
Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying disclosures. Those estimates are inherently subject to change, and actual results may ultimately differ from those estimates.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
Variable Interest Entities
Entities that do not have sufficient equity at risk to allow the entity to finance its activities without additional financial support or in which the equity investors, as a group, do not have the characteristic of a controlling financial interest are referred to as variable interest entities (“VIE”). A VIE is consolidated by the variable interest holder that is determined to have the controlling financial interest (primary beneficiary) as a result of having both the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company determines whether it is the primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE’s capital structure, contractual terms, nature of the VIE’s operations and purpose, and the Company’s relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE. The Company reassesses its VIE determination with respect to an entity on an ongoing basis.
The Company holds interests in VIEs through certain equity method investments included in “other invested assets” in the accompanying condensed consolidated balance sheets. The Company has determined that it should not consolidate any of the VIEs as it is not the primary beneficiary in any of the relationships. Although the investments resulted in the Company holding variable interests in the entities, they did not empower the Company to direct the activities that most significantly impact the economic performance of the entities. The Company’s investments related to these VIEs totaled $29.0 million and $30.1 million at March 31, 2021 and December 31, 2020, respectively, representing the Company’s maximum exposure to loss.
Income Tax Expense
Our effective tax rate fluctuates from period to period based on the relative mix of income reported by country and the respective tax rates imposed by each tax jurisdiction. For U.S.-sourced income, the Company’s U.S. federal income tax expense differs from the amounts computed by applying the federal statutory income tax rate to income before taxes due primarily to interest income on tax-advantaged state and municipal securities, dividends received income, and excess tax benefits on share based compensation. The Company had a pre-tax loss of $140.8 million for the three months ended March 31, 2021 and recorded a U.S. federal income tax benefit of $37.4 million. The pre-tax loss was largely driven by the $170.1 million of net adverse reserve development on prior accident years, including $168.7 million of net adverse development from the Excess and Surplus Lines segment that was primarily related to a former commercial auto account. For the three months ended March 31, 2021, our U.S. federal income tax benefit was 26.5% of the loss before taxes. The outbreak of the coronavirus pandemic in the first quarter of 2020 led to significant unrealized losses in our investment portfolio that were recognized in earnings. As a result, the Company had a pre-tax loss of $41.2 million for the three months ended March 31, 2020 and recorded a U.S. federal income tax benefit of $4.4 million. For the three months ended March 31, 2020, our U.S. federal income tax benefit was 10.7% of the loss before taxes. The change in effective tax rate for the two periods reflects changes in reserve estimates between accident years in the commercial auto business, and the related impact on the mix of income reported by country in those respective periods.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
2. Investments
The Company’s available-for-sale fixed maturity securities are summarized as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Cost or Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
| (in thousands) |
March 31, 2021 | | | | | | | |
Fixed maturity securities: | | | | | | | |
State and municipal | $ | 311,053 | | | $ | 12,249 | | | $ | (3,537) | | | $ | 319,765 | |
Residential mortgage-backed | 296,200 | | | 5,490 | | | (1,734) | | | 299,956 | |
Corporate | 737,756 | | | 32,160 | | | (7,223) | | | 762,693 | |
Commercial mortgage and asset-backed | 322,579 | | | 7,234 | | | (1,633) | | | 328,180 | |
| | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 88,145 | | | 1,663 | | | (251) | | | 89,557 | |
| | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 1,755,733 | | | $ | 58,796 | | | $ | (14,378) | | | $ | 1,800,151 | |
December 31, 2020 | | | | | | | |
Fixed maturity securities: | | | | | | | |
State and municipal | $ | 277,241 | | | $ | 19,203 | | | $ | (39) | | | $ | 296,405 | |
Residential mortgage-backed | 286,104 | | | 7,784 | | | (40) | | | 293,848 | |
Corporate | 715,145 | | | 52,098 | | | (421) | | | 766,822 | |
Commercial mortgage and asset-backed | 314,911 | | | 12,611 | | | (803) | | | 326,719 | |
| | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 97,489 | | | 2,360 | | | (1) | | | 99,848 | |
| | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 1,690,890 | | | $ | 94,056 | | | $ | (1,304) | | | $ | 1,783,642 | |
The amortized cost and fair value of available-for-sale investments in fixed maturity securities at March 31, 2021 are summarized, by contractual maturity, as follows:
| | | | | | | | | | | |
| Cost or Amortized Cost | | Fair Value |
| (in thousands) |
One year or less | $ | 110,269 | | | $ | 111,427 | |
After one year through five years | 455,605 | | | 477,392 | |
After five years through ten years | 327,033 | | | 332,488 | |
After ten years | 244,047 | | | 250,708 | |
Residential mortgage-backed | 296,200 | | | 299,956 | |
Commercial mortgage and asset-backed | 322,579 | | | 328,180 | |
| | | |
Total | $ | 1,755,733 | | | $ | 1,800,151 | |
Actual maturities may differ for some securities because borrowers have the right to call or prepay obligations with or without penalties.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
The following table shows the Company’s gross unrealized losses and fair value for available-for-sale securities aggregated by investment category and the length of time that individual securities have been in a continuous unrealized loss position:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Less Than 12 Months | | 12 Months or More | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
| (in thousands) |
March 31, 2021 | | | | | | | | | | | |
Fixed maturity securities: | | | | | | | | | | | |
State and municipal | $ | 113,279 | | | $ | (3,537) | | | $ | — | | | $ | — | | | $ | 113,279 | | | $ | (3,537) | |
Residential mortgage-backed | 115,899 | | | (1,725) | | | 342 | | | (9) | | | 116,241 | | | (1,734) | |
Corporate | 162,414 | | | (7,223) | | | — | | | — | | | 162,414 | | | (7,223) | |
Commercial mortgage and asset-backed | 85,511 | | | (1,564) | | | 9,013 | | | (69) | | | 94,524 | | | (1,633) | |
| | | | | | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 19,020 | | | (251) | | | — | | | — | | | 19,020 | | | (251) | |
| | | | | | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 496,123 | | | $ | (14,300) | | | $ | 9,355 | | | $ | (78) | | | $ | 505,478 | | | $ | (14,378) | |
December 31, 2020 | | | | | | | | | | | |
Fixed maturity securities: | | | | | | | | | | | |
State and municipal | $ | 7,193 | | | $ | (39) | | | $ | — | | | $ | — | | | $ | 7,193 | | | $ | (39) | |
Residential mortgage-backed | 3,649 | | | (40) | | | — | | | — | | | 3,649 | | | (40) | |
Corporate | 28,607 | | | (421) | | | — | | | — | | | 28,607 | | | (421) | |
Commercial mortgage and asset-backed | 18,427 | | | (447) | | | 38,802 | | | (356) | | | 57,229 | | | (803) | |
| | | | | | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 2,291 | | | (1) | | | — | | | — | | | 2,291 | | | (1) | |
| | | | | | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 60,167 | | | $ | (948) | | | $ | 38,802 | | | $ | (356) | | | $ | 98,969 | | | $ | (1,304) | |
At March 31, 2021, the Company held fixed maturity securities of 192 issuers that were in an unrealized loss position with a total fair value of $505.5 million and gross unrealized losses of $14.4 million. None of the fixed maturity securities with unrealized losses has ever missed, or been delinquent on, a scheduled principal or interest payment. At March 31, 2021, 99.3% of the Company’s fixed maturity security portfolio was rated “BBB-” or better (“investment grade”) by Standard & Poor’s or received an equivalent rating from another nationally recognized rating agency. Fixed maturity securities with ratings below investment grade by Standard & Poor’s or another nationally recognized rating agency at March 31, 2021 had an aggregate fair value of $11.9 million and an aggregate net unrealized gain of $114,000.
The Company adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments on January 1, 2020. This update changed the impairment model for available-for-sale fixed maturities and requires the Company to determine whether unrealized losses on available-for-sale fixed maturities are due to credit-related factors. An allowance for credit losses is established for any credit-related impairments, limited to the amount by which fair value is below amortized cost. Changes in the allowance for credit losses are recognized in earnings and included in net realized and unrealized gains (losses) on investments. Unrealized losses that are not credit-related will continue to be recognized in other comprehensive income.
The Company considers the extent to which fair value is below amortized cost in determining whether a credit-related loss exists. The Company also considers the credit quality rating of the security, with a special emphasis on securities downgraded below investment grade. A comparison is made between the present value of expected future cash flows for a security and its amortized cost. If the present value of future expected cash flows is less than amortized cost, a credit loss is presumed to exist and an allowance for credit losses is established. Management may conclude that a qualitative analysis is sufficient to support its conclusion that the present value of the expected cash flows equals or exceeds a security’s amortized cost. As a result of this review, management concluded that there were no credit-related impairments of fixed maturity securities at March 31, 2021, December 31, 2020, or March 31, 2020. Management does not intend to sell the securities in an unrealized loss position, and it is not “more likely than not” that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
In connection with the adoption of ASU 2016-13, the Company elected the fair value option in accounting for bank loan participations effective January 1, 2020. The targeted transition relief offered by ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief was applied to elect the fair value option to account for bank loan participations already held at the January 1, 2020 date of adoption. Under the fair value option, bank loan participations are measured at fair value, and changes in unrealized gains and losses in bank loan participations are reported in our income statement as net realized and unrealized gains (losses) on investments. At adoption on January 1, 2020, the Company applied the amendments on a modified retrospective basis, reducing the carrying value of its bank loan portfolio to fair value through an $8.4 million adjustment with a $7.8 million (net of tax) cumulative effect adjustment to reduce retained earnings.
Applying the fair value option to the bank loan portfolio increases volatility in the Company's financial statements, but management believes it is less subjective and less burdensome to implement and maintain than ASU 2016-13, which would have otherwise been required. At March 31, 2021, the Company's bank loan portfolio had an aggregate fair value of $160.9 million and unpaid principal of $168.6 million. Investment income on bank loan participations included in net investment income was $2.9 million and $4.1 million for the three months ended March 31, 2021 and 2020, respectively. Net realized and unrealized gains (losses) on investments includes gains of $3.9 million and losses of $43.9 million related to changes in unrealized gains and losses on bank loan participations in the three months ended March 31, 2021 and 2020, respectively. Management concluded that there were no credit-related impairments of bank loan participations at March 31, 2021. At March 31, 2020, there were $5.0 million of unrealized losses due to credit-related impairments. Losses due to credit-related impairments were determined based upon consultations and advice from the Company's specialized investment manager and consideration of any adverse situations that could affect the borrower's ability to repay, the estimated value of underlying collateral, and other relevant factors.
Bank loan participations generally provide a higher yield than our portfolio of fixed maturities and have a credit rating that is below investment grade (i.e. below “BBB-” for Standard & Poor’s) at the date of purchase. These bank loans are primarily senior, secured floating-rate debt rated “BB”, “B”, or “CCC” by Standard & Poor’s or an equivalent rating from another nationally recognized rating agency. These bank loans include assignments of, and participations in, performing and non-performing senior corporate debt generally acquired through primary bank syndications and in secondary markets. Bank loans consist of, but are not limited to, term loans, the funded and unfunded portions of revolving credit loans, and other similar loans and investments. Management believed that it was probable at the time that these loans were acquired that the Company would be able to collect all contractually required payments receivable.
Interest income on bank loan participations is accrued on the unpaid principal balance, and discounts and premiums on bank loan participations are amortized to income using the interest method. Generally, the accrual of interest on a bank loan participation is discontinued when the contractual payment of principal or interest has become 90 days past due or management has serious doubts about further collectability of principal or interest. A bank loan participation may remain on accrual status if it is in the process of collection and is either guaranteed or well secured. Generally, bank loan participations are restored to accrual status when the obligation is brought current, has performed in accordance with the contractual terms for a reasonable period of time, and the ultimate collectability of the total contractual principal and interest is no longer in doubt. Interest received on nonaccrual loans generally is reported as investment income. There were no bank loans on nonaccrual status at March 31, 2021 or December 31, 2020.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
The Company’s net realized and unrealized gains and losses on investments are summarized as follows:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Fixed maturity securities: | | | | | | | |
Gross realized gains | | | | | $ | 1,056 | | | $ | 215 | |
Gross realized losses | | | | | (22) | | | (1) | |
| | | | | 1,034 | | | 214 | |
Bank loan participations: | | | | | | | |
Gross realized gains | | | | | 198 | | | 103 | |
Gross realized losses | | | | | (260) | | | (1,309) | |
Changes in fair values of bank loan participations | | | | | 3,911 | | | (43,947) | |
| | | | | 3,849 | | | (45,153) | |
Equity securities: | | | | | | | |
Gross realized gains | | | | | 29 | | | — | |
Gross realized losses | | | | | (401) | | | (170) | |
Changes in fair values of equity securities | | | | | 1,745 | | | (13,315) | |
| | | | | 1,373 | | | (13,485) | |
Short-term investments and other: | | | | | | | |
Gross realized gains | | | | | 5 | | | 18 | |
Gross realized losses | | | | | — | | | (1) | |
Changes in fair values of short-term investments and other | | | | | 11 | | | — | |
| | | | | 16 | | | 17 | |
Total | | | | | $ | 6,272 | | | $ | (58,407) | |
Realized investment gains or losses are determined on a specific identification basis.
The Company invests selectively in private debt and equity opportunities. These investments, which together comprise the Company’s other invested assets, are primarily focused in renewable energy, limited partnerships, and bank holding companies.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Carrying Value | | | | | | Investment Income | | | | |
| March 31, | | December 31, | | | | Three Months Ended March 31, | | | | |
| 2021 | | 2020 | | | | | | 2021 | | 2020 | | | | |
| (in thousands) | | | | |
Renewable energy LLCs (a) | $ | 28,965 | | | $ | 30,145 | | | | | | | $ | (915) | | | $ | 834 | | | | | |
Renewable energy notes receivable (b) | 9,000 | | | — | | | | | | | 234 | | | 166 | | | | | |
Limited partnerships (c) | 13,398 | | | 11,903 | | | | | | | 929 | | | (569) | | | | | |
Bank holding companies (d) | 4,500 | | | 4,500 | | | | | | | 86 | | | 86 | | | | | |
Total other invested assets | $ | 55,863 | | | $ | 46,548 | | | | | | | $ | 334 | | | $ | 517 | | | | | |
(a)The Company’s Corporate and Other segment owns equity interests ranging from 2.6% to 32.6% in various LLCs whose principal objective is capital appreciation and income generation from owning and operating renewable energy production facilities (wind and solar). The LLCs are managed by an entity for which two former directors served as officers, and the Company’s Non-Executive Chairman has invested in certain of these LLCs. The equity method is used to account for the Company’s LLC investments. Income for the LLCs primarily reflects adjustments to the carrying values of investments in renewable energy projects to their determined fair values. The fair value adjustments are included in revenues for the LLCs. Expenses for the LLCs are not significant and are comprised of administrative and interest expenses. The Company received cash distributions from these investments totaling $265,000 and $747,000 in the three months ended March 31, 2021 and 2020, respectively.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
(b)The Company's Excess and Surplus Lines and Corporate and Other segments have invested in notes receivable for renewable energy projects. At March 31, 2021, the Company held two notes issued by an entity for which two of our former directors serve as officers. Interest on the notes, which mature in 2025, is fixed at 12%. Income from the notes was $234,000 and $166,000 for the three months ended March 31, 2021 and 2020, respectively ($104,000 and $— for the Excess and Surplus Lines segment and $130,000 and $166,000 for the Corporate and Other segment in the respective periods).
(c)The Company owns investments in limited partnerships that invest in concentrated portfolios including publicly-traded small cap equities, loans of middle market private equity sponsored companies, and tranches of distressed home loans. Income from the partnerships is recognized under the equity method of accounting. The Company’s Corporate and Other segment hold investments in limited partnerships with a total carrying value of $8.6 million at March 31, 2021. The Company recognized investment income of $754,000 and losses of $710,000 on these investments for the three months ended March 31, 2021 and 2020, respectively. The Company’s Excess and Surplus Lines segment holds investments in limited partnerships with a total carrying value of $4.8 million at March 31, 2021. Investment income of $175,000 and $141,000 was recognized on the investments for the three months ended March 31, 2021 and 2020, respectively. At March 31, 2021, the Company’s Excess and Surplus Lines segment has outstanding commitments to invest another $7.9 million in these limited partnerships.
(d)The Company's Corporate and Other segment holds $4.5 million of subordinated notes issued by a bank holding company for which the Company’s Non-Executive Chairman was previously the Lead Independent Director and an investor and for which one of the Company’s directors was an investor and is currently a holder of the subordinated notes (the "Bank Holding Company"). Interest on the notes, which mature on August 12, 2023, is fixed at 7.6% per annum. Interest income on the notes was $86,000 for both three month periods ended March 31, 2021 and 2020, respectively.
At March 31, 2021 and December 31, 2020, the Company held an investment in a CLO where one of the underlying loans was issued by the Bank Holding Company. The investment, with a carrying value of $252,000 at March 31, 2021, is classified as an available-for-sale fixed maturity.
3. Goodwill and Intangible Assets
On December 11, 2007, the Company completed an acquisition of James River Group by acquiring 100% of the outstanding shares of James River Group common stock, referred to herein as the “Merger”. The transaction was accounted for under the purchase method of accounting, and goodwill and intangible assets were recognized by the Company as a result of the transaction. Goodwill resulting from the Merger was $181.8 million at March 31, 2021 and December 31, 2020.
The gross carrying amounts and accumulated amortization for each major specifically identifiable intangible asset class were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | March 31, 2021 | | December 31, 2020 |
| Life (Years) | | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization |
| | | ($ in thousands) |
Intangible Assets | | | | | | | | | |
Trademarks | Indefinite | | $ | 22,200 | | | $ | — | | | $ | 22,200 | | | $ | — | |
Insurance licenses and authorities | Indefinite | | 8,964 | | | — | | | 8,964 | | | — | |
Identifiable intangibles not subject to amortization | | | 31,164 | | | — | | | 31,164 | | | — | |
Broker relationships | 24.6 | | 11,611 | | | 6,464 | | | 11,611 | | | 6,373 | |
Identifiable intangible assets subject to amortization | | | 11,611 | | | 6,464 | | | 11,611 | | | 6,373 | |
| | | $ | 42,775 | | | $ | 6,464 | | | $ | 42,775 | | | $ | 6,373 | |
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
4. Earnings Per Share
The following represents a reconciliation of the numerator and denominator of the basic and diluted loss per share computations contained in the condensed consolidated financial statements:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands, except share and per share amounts) |
Net loss to shareholders | | | | | $ | (103,460) | | | $ | (36,815) | |
| | | | | | | |
Weighted average common shares outstanding: | | | | | | | |
Basic | | | | | 30,713,986 | | | 30,476,307 | |
Common share equivalents | | | | | — | | | — | |
Diluted | | | | | 30,713,986 | | | 30,476,307 | |
| | | | | | | |
Loss per share: | | | | | | | |
Basic | | | | | $ | (3.37) | | | $ | (1.21) | |
Common share equivalents | | | | | — | | | — | |
Diluted | | | | | $ | (3.37) | | | $ | (1.21) | |
Common share equivalents of 306,712 and 309,443 were excluded from the calculation of diluted earnings per share for the three months ended March 31, 2021 and 2020, respectively, as net losses in the respective periods made the effects of all common share equivalents anti-dilutive.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
5. Reserve for Losses and Loss Adjustment Expenses
The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses, net of reinsurance, to the gross amounts reported in the condensed consolidated balance sheets. Reinsurance recoverables on unpaid losses and loss adjustment expenses are presented gross of a $335,000 allowance for credit losses on reinsurance balances at March 31, 2021 and March 31, 2020.
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Reserve for losses and loss adjustment expenses net of reinsurance recoverables at beginning of period | | | | | $ | 1,386,061 | | | $ | 1,377,461 | |
Add: Incurred losses and loss adjustment expenses net of reinsurance: | | | | | | | |
Current year | | | | | 103,366 | | | 95,982 | |
Prior years | | | | | 170,134 | | | 874 | |
Total incurred losses and loss and adjustment expenses | | | | | 273,500 | | | 96,856 | |
Deduct: Loss and loss adjustment expense payments net of reinsurance: | | | | | | | |
Current year | | | | | 3,194 | | | 4,271 | |
Prior years | | | | | 121,588 | | | 118,357 | |
Total loss and loss adjustment expense payments | | | | | 124,782 | | | 122,628 | |
Reserve for losses and loss adjustment expenses net of reinsurance recoverables at end of period | | | | | 1,534,779 | | | 1,351,689 | |
Add: Reinsurance recoverables on unpaid losses and loss adjustment expenses at end of period | | | | | 879,067 | | | 691,669 | |
Reserve for losses and loss adjustment expenses gross of reinsurance recoverables on unpaid losses and loss adjustment expenses at end of period | | | | | $ | 2,413,846 | | | $ | 2,043,358 | |
The Company experienced $170.1 million of net adverse reserve development in the three months ended March 31, 2021 on the reserve for losses and loss adjustment expenses held at December 31, 2020. This reserve development included $168.7 million of net adverse development in the Excess and Surplus Lines segment including $170.0 million on commercial auto business, almost entirely related to a previously canceled account that has been in runoff since 2019. The reported losses on this terminated commercial auto account meaningfully exceeded our expectations for the three months ended March 31, 2021. We had expected that reported losses would decline as the account moved further into runoff, but the continued heavy reported loss emergence in the first quarter of 2021 indicated more inherent severity than anticipated. In response, we meaningfully adjusted our actuarial methodology, resulting in a significant strengthening of reserves for this account at March 31, 2021. In prior quarters, our actuarial work for this terminated commercial auto account had been based on industry data, pricing data, experience data, average claims severity data, and blended methodologies. However, the continuation of the highly elevated reported losses in the first quarter of 2021 led us to conclude that using only our own loss experience in our paid and incurred reserve projections rather than the array of inputs that we had used in prior quarters, and giving greater weight to incurred methods, would give us a better estimate of ultimate losses on this account. The Company also experienced $1.0 million of net favorable development in the Specialty Admitted Insurance segment due to favorable development in the workers' compensation business for prior accident years, and $2.5 million of net adverse development in the Casualty Reinsurance segment.
The Company experienced $874,000 of net adverse reserve development in the three months ended March 31, 2020 on the reserve for losses and loss adjustment expenses held at December 31, 2019. This reserve development included $3,000 of favorable development in the Excess and Surplus Lines segment, $1.0 million of favorable development in the Specialty Admitted Insurance segment experienced due to favorable development in the workers' compensation business for prior accident years, and $1.9 million of adverse development in the Casualty Reinsurance segment.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
6. Other Comprehensive Loss
The following table summarizes the components of other comprehensive loss:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Unrealized losses arising during the period, before U.S. income taxes | | | | | $ | (47,300) | | | $ | (5,096) | |
U.S. income taxes | | | | | 5,453 | | | 1,378 | |
Unrealized losses arising during the period, net of U.S. income taxes | | | | | (41,847) | | | (3,718) | |
Less reclassification adjustment: | | | | | | | |
Net realized investment gains | | | | | 1,035 | | | 214 | |
U.S. income taxes | | | | | (194) | | | (13) | |
Reclassification adjustment for investment gains realized in net income | | | | | 841 | | | 201 | |
Other comprehensive loss | | | | | $ | (42,688) | | | $ | (3,919) | |
In addition to the $1.0 million and $214,000 of net realized investment gains on available-for-sale fixed maturities for the three months ended March 31, 2021 and 2020, respectively, the Company also recognized net realized and unrealized investment gains (losses) in the respective periods of $3.8 million and $(45.2) million on its investments in bank loan participations and $1.4 million and $(13.5) million on its investments in equity securities.
7. Contingent Liabilities
The Company is involved in various legal proceedings, including commercial matters and litigation regarding insurance claims arising in the ordinary course of business. The Company believes that the outcome of such matters, individually and in the aggregate, is not reasonably likely to have a material adverse effect on its consolidated financial position, results of operations or cash flows.
For a description of the potential future impacts of COVID-19 on the Company, see the “The global coronavirus outbreak could harm business and results of operations of the Company” risk factor in Part I—Item IA in our Annual Report on Form 10-K for the year ended December 31, 2020.
JRG Re has entered into three letter of credit facilities with banks as security to third-party reinsureds on reinsurance assumed by JRG Re. JRG Re has established custodial accounts to secure these letters of credit. Under a $75.0 million facility, $7.3 million of letters of credit were issued through March 31, 2021 which were secured by deposits of $14.4 million. Under a $102.5 million facility, $89.7 million of letters of credit were issued through March 31, 2021 which were secured by deposits of $113.6 million. Under a $100.0 million facility, $15.2 million of letters of credit were issued through March 31, 2021 which were secured by deposits of $28.1 million. JRG Re has also established trust accounts to secure its obligations to selected reinsureds. The total amount deposited in the trust accounts for the benefit of third-party reinsureds was $304.4 million at March 31, 2021.
The Company previously issued a set of insurance contracts to Rasier LLC and its affiliates (collectively, “Rasier”) under which the Company pays losses and loss adjustment expenses on the contracts. The Company has indemnity agreements with Rasier (non-insurance entities) and is contractually entitled to receive reimbursement for a significant portion of the losses and loss adjustment expenses paid on behalf of Rasier and other expenses incurred by the Company. Rasier is required to collateralize all amounts currently due to the Company and to provide additional collateral sufficient to cover the amounts that may be recoverable under the indemnity agreements, including, among other things, case loss and loss adjustment expense reserves, IBNR loss and loss adjustment expense reserves, extra contractual obligations and excess of policy limits liabilities. The collateral is provided through a collateral trust arrangement established in favor of the Company by a captive insurance company affiliate of Rasier.
As permitted under our indemnification agreements with Rasier and the associated trust agreement, we have withdrawn the collateral posted to the trust account. At March 31, 2021, the Company held collateral funds of $751.7 million. The funds withdrawn from the trust account, currently invested in short term securities and included in restricted cash equivalents on the Company's consolidated balance sheet, will be used to reimburse the Company for the losses and loss adjustment expenses paid on behalf of Rasier and other related expenses incurred by the Company to the extent not paid as required under the indemnity agreements.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
The Company has ongoing exposure to estimated losses and expenses on these contracts growing at a faster pace than growth in our collateral balances. In addition, we have credit exposure if our estimates of future losses and loss adjustment expenses and other amounts recoverable, which are the basis for establishing collateral balances, are lower than actual amounts paid or payable. The amount of our credit exposure in any of these instances could be material. To mitigate these risks, we closely and frequently monitor our exposure compared to our collateral held, and we request additional collateral when our analysis indicates that we have uncollateralized exposure.
8. Segment Information
The Company has four reportable segments: the Excess and Surplus Lines segment, the Specialty Admitted Insurance segment, the Casualty Reinsurance segment, and the Corporate and Other segment. Segment profit (loss) is measured by underwriting profit (loss), which is generally defined as net earned premiums less loss and loss adjustment expenses and other operating expenses of the operating segments. Gross fee income of the Excess and Surplus Lines segment and Specialty Admitted Insurance segment is included in the respective segment’s underwriting profit (loss). Gross fee income of $927,000 and $1.6 million ($— and $1.3 million for the Excess and Surplus Lines segment and $927,000 and $335,000 for the Specialty Admitted Insurance segment) was included in other income and in underwriting profit (loss) for the three months ended March 31, 2021 and 2020, respectively. Segment results are reported prior to the effects of intercompany reinsurance agreements among the Company’s insurance subsidiaries.
The following table summarizes the Company’s segment results:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Excess and Surplus Lines | | Specialty Admitted Insurance | | Casualty Reinsurance | | Corporate and Other | | Total |
| (in thousands) |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Three Months Ended March 31, 2021 | | | | | | | | | |
Gross written premiums | $ | 181,358 | | | $ | 127,036 | | | $ | 64,861 | | | $ | — | | | $ | 373,255 | |
Net earned premiums | 113,708 | | | 16,357 | | | 30,528 | | | — | | | 160,593 | |
Underwriting (loss) profit of insurance segments | (150,946) | | | 1,266 | | | (1,625) | | | — | | | (151,305) | |
Net investment income | 3,706 | | | 822 | | | 10,556 | | | 5 | | | 15,089 | |
Interest expense | — | | | — | | | — | | | 2,216 | | | 2,216 | |
Segment revenues | 118,796 | | | 18,565 | | | 45,517 | | | 102 | | | 182,980 | |
Segment goodwill | 181,831 | | | — | | | — | | | — | | | 181,831 | |
Segment assets | 2,129,985 | | | 980,824 | | | 1,930,747 | | | 68,151 | | | 5,109,707 | |
| | | | | | | | | |
Three Months Ended March 31, 2020 | | | | | | | | | |
Gross written premiums | $ | 136,197 | | | $ | 102,802 | | | $ | 44,842 | | | $ | — | | | $ | 283,841 | |
Net earned premiums | 99,739 | | | 13,283 | | | 32,896 | | | — | | | 145,918 | |
Underwriting profit (loss) of insurance segments | 8,112 | | | (988) | | | 207 | | | — | | | 7,331 | |
Net investment income | 7,941 | | | 928 | | | 11,604 | | | 363 | | | 20,836 | |
Interest expense | — | | | — | | | — | | | 2,876 | | | 2,876 | |
Segment revenues | 83,829 | | | 12,673 | | | 13,280 | | | 502 | | | 110,284 | |
Segment goodwill | 181,831 | | | — | | | — | | | — | | | 181,831 | |
Segment assets | 2,293,444 | | | 829,699 | | | 1,824,729 | | | 48,938 | | | 4,996,810 | |
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
The following table reconciles the underwriting (loss) profit of the operating segments by individual segment to consolidated loss before income taxes:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Underwriting (loss) profit of the insurance segments: | | | | | | | |
Excess and Surplus Lines | | | | | $ | (150,946) | | | $ | 8,112 | |
Specialty Admitted Insurance | | | | | 1,266 | | | (988) | |
Casualty Reinsurance | | | | | (1,625) | | | 207 | |
Total underwriting (loss) profit of insurance segments | | | | | (151,305) | | | 7,331 | |
Other operating expenses of the Corporate and Other segment | | | | | (8,056) | | | (8,279) | |
Underwriting loss | | | | | (159,361) | | | (948) | |
Net investment income | | | | | 15,089 | | | 20,836 | |
Net realized and unrealized gains (losses) on investments | | | | | 6,272 | | | (58,407) | |
Amortization of intangible assets | | | | | (91) | | | (149) | |
Other income and expenses | | | | | (522) | | | 326 | |
Interest expense | | | | | (2,216) | | | (2,876) | |
Loss before income taxes | | | | | $ | (140,829) | | | $ | (41,218) | |
9. Other Operating Expenses and Other Expenses
Other operating expenses consist of the following:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Amortization of policy acquisition costs | | | | | $ | 21,475 | | | $ | 24,116 | |
Other underwriting expenses of the operating segments | | | | | 17,850 | | | 19,226 | |
Other operating expenses of the Corporate and Other segment | | | | | 8,056 | | | 8,279 | |
Total | | | | | $ | 47,381 | | | $ | 51,621 | |
Other expenses of $621,000 for the three months ended March 31, 2021 primarily consist of employee severance and certain legal and professional consulting fees related to various strategic initiatives. There were no expenses classified as other for the three months ended March 31, 2020.
10. Fair Value Measurements
Three levels of inputs are used to measure fair value of financial instruments: (1) Level 1: quoted price (unadjusted) in active markets for identical assets, (2) Level 2: inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument, and (3) Level 3: inputs to the valuation methodology are unobservable for the asset or liability.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.
The fair values of fixed maturity securities, equity securities, and bank loan participations have been determined using fair value prices provided by the Company's investment accounting services provider or investment managers, who utilize internationally recognized independent pricing services. The prices provided by the independent pricing services are generally based on observable market data in active markets (e.g. broker quotes and prices observed for comparable securities). Values for U.S. Treasury and publicly-traded equity securities are generally based on Level 1 inputs which use the market approach valuation technique. The values for all other fixed maturity securities (including state and municipal securities and obligations of U.S. government corporations and agencies) and bank loan participations generally incorporate significant Level 2 inputs, and in some cases, Level 3 inputs, using the market approach and income approach valuation techniques. There have been no changes in the Company’s use of valuation techniques since December 31, 2019.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
The Company reviews fair value prices provided by its outside investment accounting service provider or investment managers for reasonableness by comparing the fair values provided by the managers to those provided by its investment custodian. The Company also reviews and monitors changes in unrealized gains and losses. The Company has not historically adjusted security prices. The Company obtains an understanding of the methods, models and inputs used by the investment managers and independent pricing services, and controls are in place to validate that prices provided represent fair values. The Company’s control process includes, but is not limited to, initial and ongoing evaluation of the methodologies used, a review of specific securities and an assessment for proper classification within the fair value hierarchy, and obtaining and reviewing internal control reports for our investment manager that obtains fair values from independent pricing services.
Assets measured at fair value on a recurring basis as of March 31, 2021 are summarized below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value Measurements Using |
| Quoted Prices in Active Markets for Identical Assets Level 1 | | Significant Other Observable Inputs Level 2 | | Significant Unobservable Inputs Level 3 | | Total |
| (in thousands) |
Fixed maturity securities, available-for-sale: | | | | | | | |
State and municipal | $ | — | | | $ | 319,765 | | | $ | — | | | $ | 319,765 | |
Residential mortgage-backed | — | | | 299,956 | | | — | | | 299,956 | |
Corporate | — | | | 762,693 | | | — | | | 762,693 | |
Commercial mortgage and asset-backed | — | | | 328,180 | | | — | | | 328,180 | |
| | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 89,118 | | | 439 | | | — | | | 89,557 | |
| | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 89,118 | | | $ | 1,711,033 | | | $ | — | | | $ | 1,800,151 | |
Equity securities: | | | | | | | |
Preferred stock | — | | | 62,079 | | | — | | | 62,079 | |
Common stock | 21,464 | | | 7,334 | | | — | | | 28,798 | |
Total equity securities | $ | 21,464 | | | $ | 69,413 | | | $ | — | | | $ | 90,877 | |
| | | | | | | |
Bank loan participations | $ | — | | | $ | 160,581 | | | $ | 299 | | | $ | 160,880 | |
Short-term investments | $ | — | | | $ | 51,198 | | | $ | — | | | $ | 51,198 | |
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
Assets measured at fair value on a recurring basis as of December 31, 2020 are summarized below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value Measurements Using |
| Quoted Prices in Active Markets for Identical Assets Level 1 | | Significant Other Observable Inputs Level 2 | | Significant Unobservable Inputs Level 3 | | Total |
| (in thousands) |
Fixed maturity securities, available-for-sale: | | | | | | | |
State and municipal | $ | — | | | $ | 296,405 | | | $ | — | | | $ | 296,405 | |
Residential mortgage-backed | — | | | 293,848 | | | — | | | 293,848 | |
Corporate | — | | | 766,822 | | | — | | | 766,822 | |
Commercial mortgage and asset-backed | — | | | 326,719 | | | | | 326,719 | |
| | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 99,384 | | | 464 | | | — | | | 99,848 | |
| | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 99,384 | | | $ | 1,684,258 | | | $ | — | | | $ | 1,783,642 | |
Equity securities: | | | | | | | |
Preferred stock | — | | | 67,495 | | | — | | | 67,495 | |
Common stock | 15,793 | | | 5,015 | | | 672 | | | 21,480 | |
Total equity securities | $ | 15,793 | | | $ | 72,510 | | | $ | 672 | | | $ | 88,975 | |
Bank loan participations | $ | — | | | $ | 147,296 | | | $ | 308 | | | $ | 147,604 | |
Short-term investments | $ | — | | | $ | 130,289 | | | $ | — | | | $ | 130,289 | |
A reconciliation of the beginning and ending balances of available-for-sale fixed maturity securities, equity securities, and bank loan participations measured at fair value on a recurring basis (as a result of the fair value option effective January 1, 2020) using significant unobservable inputs (Level 3) is shown below:
| | | | | | | | | | | | | | | |
| | | Three Months Ended |
| | | | | March 31, 2021 | | March 31, 2020 |
| | | (in thousands) |
Beginning balance | | | | | $ | 980 | | | $ | 43 | |
Transfers out of Level 3 | | | | | — | | | — | |
Transfers in to Level 3 | | | | | — | | | 358 | |
Purchases | | | | | — | | | 703 | |
Sales | | | | | (282) | | | — | |
Maturities, calls and paydowns | | | | | (24) | | | (17) | |
Amortization of discount | | | | | — | | | 3 | |
Total gains or losses (realized/unrealized): | | | | | | | |
Included in earnings | | | | | (375) | | | (58) | |
Included in other comprehensive income | | | | | — | | | — | |
Ending balance | | | | | $ | 299 | | | $ | 1,032 | |
The Company held one bank loan participation and one equity security at March 31, 2021 and one bank loan participation and two equity securities at December 31, 2020 for which the fair value was determined using significant unobservable inputs (Level 3). A market approach using prices in trades of comparable securities was utilized to determine a fair value for the securities of $299,000 at March 31, 2021 and $980,000 at December 31, 2020.
The Company held one equity security at December 31, 2019 and three bank loan participations and two equity securities at March 31, 2020 for which the fair value was determined using significant unobservable inputs (Level 3). A market approach
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
using prices in trades of comparable securities was utilized to determine a fair value for the securities of $1.0 million at March 31, 2020 and $43,000 at December 31, 2019.
Transfers out of Level 3 occur when the Company is able to obtain reliable prices from pricing vendors for securities for which the Company was previously unable to obtain reliable prices. Transfers in to Level 3 occur when the Company is unable to obtain reliable prices for securities from pricing vendors and instead must use broker price quotes to value the securities.
There were no transfers between Level 1 and Level 2 during the three months ended March 31, 2021 or 2020. The Company recognizes transfers between levels at the beginning of the reporting period.
In the determination of the fair value for bank loan participations and certain high yield bonds, the Company’s investment manager endeavors to obtain data from multiple external pricing sources. External pricing sources may include brokers, dealers and price data vendors that provide a composite price based on prices from multiple dealers. Such external pricing sources typically provide valuations for normal institutional size trading units of such securities using methods based on market transactions for comparable securities, and various relationships between securities, as generally recognized by institutional dealers. For investments in which the investment manager determines that only one external pricing source is appropriate or if only one external price is available, the relevant investment is generally recorded at fair value based on such price.
Investments for which external sources are not available or are determined by the investment manager not to be representative of fair value are recorded at fair value as determined by the Company, with input from its investment managers and valuation specialists as considered necessary. In determining the fair value of such investments, the Company considers one or more of the following factors: type of security held, convertibility or exchangeability of the security, redeemability of the security (including the timing of redemptions), application of industry accepted valuation models, recent trading activity, liquidity, estimates of liquidation value, purchase cost, and prices received for securities with similar terms of the same issuer or similar issuers. At March 31, 2021 and December 31, 2020, there were no investments for which external sources were unavailable to determine fair value.
The carrying values and fair values of financial instruments are summarized below:
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2021 | | December 31, 2020 |
| Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
| (in thousands) |
Assets | | | | | | | |
Fixed maturity securities, available-for-sale | $ | 1,800,151 | | | $ | 1,800,151 | | | $ | 1,783,642 | | | $ | 1,783,642 | |
Equity securities | 90,877 | | | 90,877 | | | 88,975 | | | 88,975 | |
| | | | | | | |
Bank loan participations | 160,880 | | | 160,880 | | | 147,604 | | | 147,604 | |
Cash and cash equivalents | 183,491 | | | 183,491 | | | 162,260 | | | 162,260 | |
Restricted cash equivalents | 751,668 | | | 751,668 | | | 859,920 | | | 859,920 | |
Short-term investments | 51,198 | | | 51,198 | | | 130,289 | | | 130,289 | |
Other invested assets – notes receivable | 13,500 | | | 17,767 | | | 4,500 | | | 5,302 | |
Liabilities | | | | | | | |
Senior debt | 262,300 | | | 245,670 | | | 262,300 | | | 250,953 | |
Junior subordinated debt | 104,055 | | | 101,553 | | | 104,055 | | | 110,612 | |
The fair values of fixed maturity securities, equity securities, and bank loan participations have been determined using quoted market prices for securities traded in the public market or prices using bid or closing prices for securities not traded in the public marketplace. The fair values of cash and cash equivalents and short-term investments approximate their carrying values due to their short-term maturity.
The fair values of other invested assets-notes receivable, senior debt, and junior subordinated debt at March 31, 2021 and December 31, 2020 were determined by calculating the present value of expected future cash flows under the terms of the note agreements or debt agreements, as applicable, discounted at an estimated market rate of interest at March 31, 2021 and December 31, 2020, respectively.
The fair values of senior debt and junior subordinated debt at March 31, 2021 and December 31, 2020 were determined using inputs to the valuation methodology that are unobservable (Level 3).
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
11. Senior Debt
At March 31, 2021, the Company had a drawn balance of $185.8 million outstanding on the $212.5 million unsecured revolving facility in its $315.0 million senior revolving credit facility (as amended or amended and restated, the "2013 Facility”). The 2013 Facility contains certain financial and other covenants (including minimum net worth, maximum ratio of total adjusted debt outstanding to total capitalization, and financial strength ratings) with which the Company was in compliance at March 31, 2021. In the three months ended March 31, 2020, the Company drew $60.0 million on the unsecured revolver as a precautionary measure to increase the Company's cash position and preserve financial flexibility in light of uncertainty in the global markets resulting from the coronavirus (COVID-19) outbreak.
At March 31, 2021, unsecured loans of $61.5 million and secured letters of credit totaling $15.2 million were outstanding under a credit agreement (the "2017 Facility") that provides the Company with a revolving line of credit of up to $100.0 million, which may be used for loans and letters of credit made or issued, at the borrowers' option, on a secured or unsecured basis. The 2017 Facility contains certain financial and other covenants which the Company was in compliance with at March 31, 2021. In the three months ended March 31, 2020, the Company drew $59.0 million of unsecured capacity as a precautionary measure to increase the Company's cash position and preserve financial flexibility in light of uncertainty in the global markets resulting from the coronavirus (COVID-19) outbreak.
12. Capital Stock and Equity Awards
The Company issued 125,669 common shares in the three months ended March 31, 2021. 16,471 of the new shares were related to stock option exercises and 109,198 were related to vesting of restricted share units (“RSUs”). The total common shares outstanding increased from 30,649,261 at December 31, 2020 to 30,774,930 at March 31, 2021.
The Company declared the following dividends during the first three months of 2021 and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Date of Declaration | | Dividend per Common Share | | Payable to Shareholders of Record on | | Payment Date | | Total Amount (thousands) |
| | | | | | | | |
2021 | | | | | | | | |
February 24, 2021 | | $ | 0.30 | | | March 15, 2021 | | March 31, 2021 | | $ | 9,345 | |
| | | | | | | | |
2020 | | | | | | | | |
February 19, 2020 | | $ | 0.30 | | | March 16, 2020 | | March 31, 2020 | | $ | 9,269 | |
Included in the total dividends for each of the three months ended March 31, 2021 and 2020, respectively, are $113,000 of dividend equivalents on unvested RSUs. The balance of dividends payable on unvested RSUs was $396,000 at March 31, 2021 and $663,000 at December 31, 2020.
Equity Incentive Plans
The Company’s shareholders have approved various equity incentive plans, including the Amended and Restated 2009 Equity Incentive Plan (the “Legacy Plan”), the 2014 Long Term Incentive Plan (“2014 LTIP”), and the 2014 Non-Employee Director Incentive Plan (“2014 Director Plan”) (collectively, the “Plans”). All awards issued under the Plans are issued at the discretion of the Board of Directors. Under the Legacy Plan, employees received non-qualified stock options. Options are outstanding under the Legacy Plan; however, no additional awards may be granted.
Employees are eligible to receive non-qualified stock options, incentive stock options, share appreciation rights, performance shares, restricted shares, RSUs, and other awards under the 2014 LTIP. The maximum number of shares available for issuance under the 2014 LTIP is 4,171,150, and at March 31, 2021, 1,226,493 shares are available for grant.
Non-employee directors of the Company are eligible to receive non-qualified stock options, share appreciation rights, performance shares, restricted shares, RSUs, and other awards under the 2014 Director Plan. The maximum number of shares available for issuance under the 2014 Director Plan is 150,000, and at March 31, 2021, 94,781 shares are available for grant.
Generally, awards issued under the 2014 LTIP and 2014 Director Plan vest immediately in the event that an award recipient is terminated without Cause (as defined in the applicable plans), and in the case of the 2014 LTIP for Good Reason (as defined in the applicable plans), at any time following a Change in Control (as defined in the applicable plans).
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
Options
The following table summarizes option activity:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Shares | | Weighted- Average Exercise Price | | Shares | | Weighted- Average Exercise Price |
Outstanding: | | | | | | | |
Beginning of period | 463,324 | | | $ | 32.25 | | | 643,851 | | | $ | 30.41 | |
Granted | — | | | $ | — | | | — | | | $ | — | |
Exercised | (29,884) | | | $ | 26.37 | | | — | | | $ | — | |
Forfeited | — | | | $ | — | | | — | | | $ | — | |
End of period | 433,440 | | | $ | 32.65 | | | 643,851 | | | $ | 30.41 | |
Exercisable, end of period | 433,440 | | | $ | 32.65 | | | 640,606 | | | $ | 30.35 | |
All of the outstanding options are fully vested (vesting period of three years from date of grant) and have a contractual life of seven years from the original date of grant. All of the outstanding options have an exercise price equal to the fair value of the underlying shares at the date of grant. The weighted-average remaining contractual life of the options outstanding and exercisable at March 31, 2021 was 1.9 years.
RSUs
The following table summarizes RSU activity:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Shares | | Weighted- Average Grant Date Fair Value | | Shares | | Weighted- Average Grant Date Fair Value |
| | | | | | | |
Unvested, beginning of period | 399,856 | | | $ | 43.59 | | | 340,368 | | | $ | 41.50 | |
Granted | 138,936 | | | $ | 50.24 | | | 179,016 | | | $ | 43.55 | |
Vested | (161,004) | | | $ | 41.89 | | | (142,830) | | | $ | 41.16 | |
Forfeited | (1,089) | | | $ | 42.44 | | | (1,188) | | | $ | 42.07 | |
Unvested, end of period | 376,699 | | | $ | 46.78 | | | 375,366 | | | $ | 42.61 | |
Outstanding RSUs granted to employees vest ratably over a three year vesting period. RSUs granted to non-employee directors have a one year vesting period. The holders of RSUs are entitled to dividend equivalents. The dividend equivalents are settled in cash at the same time that the underlying RSUs vest and are subject to the same risk of forfeiture as the underlying shares. The fair value of the RSUs granted is based on the market price of the underlying shares at the date of grant.
Compensation Expense
Share based compensation expense is recognized on a straight line basis over the vesting period. The amount of expense and related tax benefit is summarized below:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Share based compensation expense | | | | | $ | 1,905 | | | $ | 1,867 | |
U.S. tax benefit on share based compensation expense | | | | | 294 | | | 250 | |
As of March 31, 2021, the Company had $16.2 million of unrecognized share based compensation expense expected to be charged to earnings over a weighted-average period of 2.3 years.
JAMES RIVER GROUP HOLDING, LTD. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (continued)
13. Subsequent Events
On April 27, 2021, the Board of Directors declared a cash dividend of $0.30 per common share. The dividend is payable on June 30, 2021 to shareholders of record on June 14, 2021.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. Factors that could cause such differences are discussed in the sections entitled “Special Note Regarding Forward-Looking Statements” and Part II, Item 1A “Risk Factors” in this Quarterly Report on Form 10-Q, or “Quarterly Report”, and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021, or for any other future period. The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report, and in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2020.
The accompanying condensed consolidated financial statements and related notes have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and include the accounts of James River Group Holdings, Ltd. and its subsidiaries. Unless the context indicates or suggests otherwise, references to “the Company”, “we”, “us” and “our” refer to James River Group Holdings, Ltd. and its subsidiaries.
Our Business
James River Group Holdings, Ltd. is a Bermuda-based holding company. We own and operate a group of specialty insurance and reinsurance companies with the objective of generating compelling returns on tangible equity while limiting underwriting and investment volatility. We seek to accomplish this by consistently earning profits from insurance and reinsurance underwriting and generating meaningful risk-adjusted investment returns while managing our capital opportunistically.
We are organized into four reportable segments, which are separately managed business units:
•The Excess and Surplus Lines segment offers commercial excess and surplus lines liability and property insurance in every U.S. state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands through James River Insurance Company and its wholly-owned subsidiary, James River Casualty Company;
•The Specialty Admitted Insurance segment approaches the insurance market in two ways: as a risk bearing underwriter, and as a “fronting” company. The Company’s risk bearing underwriting is focused on niche classes within the standard insurance markets, such as workers’ compensation coverage for residential contractors, light manufacturing operations, transportation workers and healthcare workers. In its fronting business, the Specialty Admitted segment works with distributors, such as MGAs and other producers, by using our licensure, rating and administrative services in order to produce and service insurance policies for reinsurers and other third party risk bearing entities. We charge fees for “fronting” for these capital providers. In some instances, we retain a small percentage of the risk on fronted business. This segment has admitted licenses and the authority to write excess and surplus lines insurance in 50 states and the District of Columbia;
•The Casualty Reinsurance segment primarily provides proportional and working layer casualty reinsurance to third parties (primarily through reinsurance intermediaries) and stop loss reinsurance to Carolina Re Ltd (“Carolina Re”), through JRG Reinsurance Company Ltd. (“JRG Re”), both Bermuda-based reinsurance companies. JRG Re has also in the past provided reinsurance to the Company's U.S. based insurance subsidiaries through a quota-share reinsurance agreement; Carolina Re was formed in 2018 to do this as well; and
•The Corporate and Other segment consists of the management and treasury activities of our holding companies, interest expense associated with our debt, and expenses of our holding companies, including public company expenses, that are not reimbursed by our insurance segments.
All of our insurance and reinsurance subsidiaries have financial strength ratings of “A” (Excellent) from A.M. Best Company.
Critical Accounting Policies and Estimates
In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ significantly from those estimates.
The most critical accounting policies involve significant estimates and include those used in determining the reserve for losses and loss adjustment expenses, investment valuation and impairment, and assumed reinsurance premiums. For a detailed discussion of each of these policies, refer to our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no significant changes to any of these policies during the current year.
Impact of the COVID-19 Pandemic
For a discussion of the impact of the coronavirus (COVID-19) pandemic and related economic conditions on the Company’s results for the year ended December 31, 2020, please see “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operation” in our Annual Report. The Company continues to monitor the impact that the outbreak of the coronavirus (COVID-19) pandemic may be having on the Company’s financial condition and results of operations.
RESULTS OF OPERATIONS
The following table summarizes our results:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) | | |
Gross written premiums | | | | | | | $ | 373,255 | | | $ | 283,841 | | | 31.5 | % |
Net retention (1) | | | | | | | 46.8 | % | | 47.4 | % | | |
Net written premiums | | | | | | | $ | 174,599 | | | $ | 134,654 | | | 29.7 | % |
Net earned premiums | | | | | | | $ | 160,593 | | | $ | 145,918 | | | 10.1 | % |
Losses and loss adjustment expenses | | | | | | | (273,500) | | | (96,856) | | | 182.4 | % |
Other operating expenses | | | | | | | (46,454) | | | (50,010) | | | (7.1) | % |
Underwriting loss (2), (3) | | | | | | | (159,361) | | | (948) | | | — | |
Net investment income | | | | | | | 15,089 | | | 20,836 | | | (27.6) | % |
Net realized and unrealized gains (losses) on investments | | | | | | | 6,272 | | | (58,407) | | | — | |
Other income and expense | | | | | | | (522) | | | 326 | | | — | |
Interest expense | | | | | | | (2,216) | | | (2,876) | | | (22.9) | % |
Amortization of intangible assets | | | | | | | (91) | | | (149) | | | (38.9) | % |
Loss before taxes | | | | | | | (140,829) | | | (41,218) | | | 241.7 | % |
Income tax benefit | | | | | | | (37,369) | | | (4,403) | | | 748.7 | % |
Net loss | | | | | | | $ | (103,460) | | | $ | (36,815) | | | 181.0 | % |
Adjusted net operating (loss) income (4) | | | | | | | $ | (108,795) | | | $ | 15,418 | | | — | |
Ratios: | | | | | | | | | | | |
Loss ratio | | | | | | | 170.3 | % | | 66.4 | % | | |
Expense ratio | | | | | | | 28.9 | % | | 34.2 | % | | |
Combined ratio | | | | | | | 199.2 | % | | 100.6 | % | | |
Accident year loss ratio (5) | | | | | | | 64.4 | % | | 65.8 | % | | |
(1)Net retention is defined as the ratio of net written premiums to gross written premiums.
(2)Underwriting loss is a non-GAAP measure. See “Reconciliation of Non-GAAP Measures” for a reconciliation to loss before taxes and for additional information.
(3)Included in underwriting results for the three months ended March 31, 2021 and 2020 is gross fee income of $5.1 million and $5.5 million, respectively.
(4)Adjusted net operating (loss) income is a non-GAAP measure. See “Reconciliation of Non-GAAP Measures” for reconciliation to net loss and for additional information.
(5)Accident year loss ratio is defined as the ratio of losses and loss adjustment expenses for the current accident year (excluding development on prior accident year reserves) to net earned premiums.
Three Months Ended March 31, 2021 and 2020
The Company had an underwriting loss of $159.4 million for the three months ended March 31, 2021. This compares to an underwriting loss of $948,000 for the same period in the prior year. Net adverse reserve development on prior accident years was the principal driver of the underwriting losses for both periods. Underwriting results for the three months ended March 31, 2021 include $170.1 million of net adverse reserve development on prior accident years, including $168.7 million of net adverse development from the Excess and Surplus Lines segment almost entirely related to a previously canceled commercial auto account that has been in runoff since 2019 (see underwriting results of the Excess and Surplus Lines segment below for further discussion). Underwriting results for the three months ended March 31, 2020 included $874,000 of net adverse reserve development on prior accident years.
The results for the three months ended March 31, 2021 and 2020 include certain non-operating items that are significant to the Company. These items (on a pre-tax basis) include:
•Net realized and unrealized investment gains (losses) of $6.3 million and $(58.4) million for the three months ended March 31, 2021 and 2020, respectively. For the three months ended March 31, 2021, net realized and unrealized gains
on investments include $1.7 million and $3.9 million related to changes in unrealized gains and losses on equity securities and bank loan participations, respectively ($(13.3) million and $(43.9) million of net realized and unrealized losses for the three months ended March 31, 2020, respectively). The outbreak of the coronavirus pandemic in the first quarter of 2020 and uncertainty around the extent of its economic impact caused severe declines in financial markets, leading to significant net unrealized losses recognized in earnings. See “— Investing Results" for more information on these realized and unrealized investment gains (losses).
We define adjusted net operating (loss) income as net loss excluding net realized and unrealized gains (losses) on investments, and certain non-operating expenses such as professional service fees related to various strategic initiatives and the filing of registration statements for the offering of securities, and severance costs associated with terminated employees. We use adjusted net operating (loss) income as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted net operating (loss) income should not be viewed as a substitute for net loss calculated in accordance with GAAP, and our definition of adjusted net operating (loss) income may not be comparable to that of other companies.
Our loss before taxes and net loss reconcile to our adjusted net operating (loss) income as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Loss Before Taxes | | Net Loss | | (Loss) Income Before Taxes | | Net (Loss) Income |
| ($ in thousands) |
Loss as reported | $ | (140,829) | | | $ | (103,460) | | | $ | (41,218) | | | $ | (36,815) | |
Net realized and unrealized investment (gains) losses | (6,272) | | | (5,751) | | | 58,407 | | | 52,233 | |
Other expenses | 527 | | | 416 | | | — | | | — | |
Adjusted net operating (loss) income | $ | (146,574) | | | $ | (108,795) | | | $ | 17,189 | | | $ | 15,418 | |
Combined Ratios
The combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and other operating expenses to net earned premiums. Our combined ratio for the three months ended March 31, 2021 was 199.2%. A combined ratio of less than 100% indicates an underwriting profit, while a combined ratio greater than 100% reflects an underwriting loss. The combined ratio for the three months ended March 31, 2021 includes $170.1 million, or 105.9 percentage points, of net adverse reserve development on prior accident years, including $168.7 million of net adverse reserve development from the Excess and Surplus Lines segment (see underwriting results of the Excess and Surplus Lines segment for further discussion), $1.0 million of net favorable reserve development from the Specialty Admitted Insurance segment, and $2.5 million of net adverse reserve development from the Casualty Reinsurance segment.
The combined ratio for the three months ended March 31, 2020 was 100.6%. The combined ratio for the three months ended March 31, 2020 includes $874,000, or 0.6 percentage points, of net adverse reserve development on prior accident years, including $3,000 of net favorable reserve development from the Excess and Surplus Lines segment, $1.0 million of net favorable reserve development from the Specialty Admitted Insurance segment, and $1.9 million of net adverse reserve development from the Casualty Reinsurance segment.
All of the Company’s U.S.-domiciled insurance subsidiaries are party to an intercompany pooling agreement that distributes the net underwriting results among the group companies based on their approximate pro-rata level of statutory capital and surplus to the total Company statutory capital and surplus. Additionally, each of the Company’s U.S.-domiciled insurance subsidiaries is a party to a quota share reinsurance agreement that in periods prior to January 1, 2018 ceded 70% of their premiums and losses to JRG Re, and starting January 1, 2018, ceded 70% of their premiums and losses to Carolina Re, an entity domiciled in Bermuda that made an irrevocable election to be taxed as a U.S. domestic corporation under Section 953(d) of the Code effective January 1, 2018. JRG Re also provides stop loss reinsurance to Carolina Re. We report all segment information in this ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’ prior to the effects of intercompany reinsurance, consistent with the manner in which we evaluate the operating performance of our reportable segments.
Expense Ratios
Our expense ratio decreased from 34.2% for the three months ended March 31, 2020 to 28.9% for the three months ended March 31, 2021. The decrease reflects a 16.4% increase in the Core E&S net earned premiums of the Excess and Surplus Lines segment including in lines that have meaningful ceding commissions. Our Excess and Surplus Lines segment has significant
scale and produces a lower expense ratio than our other operating segments. The Excess and Surplus Lines segment is our largest segment and makes up 70.8% of consolidated net earned premiums for the three months ended March 31, 2021 compared to 68.4% for three months ended March 31, 2020. Gross fee income for the Company declined from $5.5 million for the three months ended March 31, 2020 to $5.1 million for the three months ended March 31, 2021. The termination of a commercial auto account resulted in a $1.3 million decline of gross fee income in the Excess and Surplus Lines segment for the three months ended March 31, 2021. This was partially offset by $917,000 higher fee income in the Specialty Admitted Insurance segment due to new fronting programs and growth in existing fronting programs.
Premiums
Insurance premiums are earned ratably over the terms of our insurance policies, generally twelve months. Reinsurance premiums assumed are earned over the terms of the underlying policies or reinsurance contracts. Reinsurance contracts written on a “losses occurring” basis cover claims that may occur during the term of the contract or underlying insurance policy, which is typically twelve months. Reinsurance contracts which are written on a “risks attaching” basis cover claims which attach to the underlying insurance policies written during the terms of such contracts. Premiums earned on such contracts usually extend beyond the original term of the reinsurance contract, typically resulting in recognition of premiums earned over a 24-month period in proportion to the level of underlying exposure.
The following table summarizes the change in premium volume by component and business segment:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) | | |
Gross written premiums: | | | | | | | | | | | |
Excess and Surplus Lines | | | | | | | $ | 181,358 | | | $ | 136,197 | | | 33.2 | % |
Specialty Admitted Insurance | | | | | | | 127,036 | | | 102,802 | | | 23.6 | % |
Casualty Reinsurance | | | | | | | 64,861 | | | 44,842 | | | 44.6 | % |
| | | | | | | $ | 373,255 | | | $ | 283,841 | | | 31.5 | % |
Net written premiums: | | | | | | | | | | | |
Excess and Surplus Lines | | | | | | | $ | 108,433 | | | $ | 92,206 | | | 17.6 | % |
Specialty Admitted Insurance | | | | | | | 22,005 | | | 13,356 | | | 64.8 | % |
Casualty Reinsurance | | | | | | | 44,161 | | | 29,092 | | | 51.8 | % |
| | | | | | | $ | 174,599 | | | $ | 134,654 | | | 29.7 | % |
Net earned premiums: | | | | | | | | | | | |
Excess and Surplus Lines | | | | | | | $ | 113,708 | | | $ | 99,739 | | | 14.0 | % |
Specialty Admitted Insurance | | | | | | | 16,357 | | | 13,283 | | | 23.1 | % |
Casualty Reinsurance | | | | | | | 30,528 | | | 32,896 | | | (7.2) | % |
| | | | | | | $ | 160,593 | | | $ | 145,918 | | | 10.1 | % |
Gross written premiums for the Excess and Surplus Lines segment (which represents 48.6% of our consolidated gross written premiums in the three months ended March 31, 2021) increased 33.2% from the corresponding three month period in the prior year. Policy submissions excluding commercial auto policies were slightly lower by 0.6%, yet 15.5% more policies were bound in the three months ended March 31, 2021 than in the three months ended March 31, 2020. Renewal rates for the Excess and Surplus Lines segment were up 14.6% compared to the three months ended March 31, 2020. The change in gross written premiums compared to the same period in 2020 was notable in several divisions as shown below:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) |
Excess Casualty | | | | | | | $ | 68,401 | | | $ | 34,207 | | | 100.0 | % |
General Casualty | | | | | | | 29,379 | | | 25,722 | | | 14.2 | % |
Manufacturers & Contractors | | | | | | | 31,855 | | | 28,330 | | | 12.4 | % |
Allied Health | | | | | | | 8,241 | | | 5,449 | | | 51.2 | % |
Small Business | | | | | | | 7,462 | | | 5,629 | | | 32.6 | % |
All other Core E&S divisions | | | | | | | 30,232 | | | 30,125 | | | 0.4 | % |
Total Core E&S divisions | | | | | | | 175,570 | | | 129,462 | | | 35.6 | % |
Commercial Auto | | | | | | | 5,788 | | | 6,735 | | | (14.1) | % |
Excess and Surplus Lines gross written premium | | | | | | | $ | 181,358 | | | $ | 136,197 | | | 33.2 | % |
The components of gross written premiums for the Specialty Admitted Insurance segment (which represents 34.0% of our consolidated gross written premiums for the three months ended March 31, 2021) are as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) |
Individual risk workers’ compensation premium | | | | | | | $ | 16,186 | | | $ | 17,480 | | | (7.4) | % |
Fronting and program premium | | | | | | | 110,850 | | | 85,322 | | | 29.9 | % |
Specialty Admitted gross written premium | | | | | | | $ | 127,036 | | | $ | 102,802 | | | 23.6 | % |
The premium growth in fronting and programs was largely driven by eight new fronting relationships that generated $23.5 million of gross written premium in the three months ended March 31, 2021. Our largest fronting relationship produced $33.9 million of gross written premium for the three months ended March 31, 2021, up from $32.7 million for the three months ended March 31, 2020 and representing 26.7% of the segment's gross written premium in the three months ended March 31, 2021 down from 31.9% in the three months ended March 31, 2020.
Gross written premiums for the Casualty Reinsurance segment (which represents 17.4% of our consolidated gross written premiums in the first three months of 2021) increased 44.6% from the corresponding three month period in the prior year. The increase in gross written premiums was due to a change in renewal date for one treaty. The Casualty Reinsurance segment generally writes large casualty-focused treaties that are expected to have lower volatility relative to property and catastrophe treaties. We rarely write stand-alone property reinsurance. When treaties that include property exposure are written, we utilize property occurrence caps, inuring reinsurance protection and low individual risk limits to minimize exposure.
Net Retention
The ratio of net written premiums to gross written premiums is referred to as our net premium retention. Our net premium retention is summarized by segment as follows:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
Excess and Surplus Lines | | | | | 59.8 | % | | 67.7 | % |
Specialty Admitted Insurance | | | | | 17.3 | % | | 13.0 | % |
Casualty Reinsurance | | | | | 68.1 | % | | 64.9 | % |
Total | | | | | 46.8 | % | | 47.4 | % |
The net premium retention for the Excess and Surplus Lines segment decreased for the three months ended March 31, 2021 as compared to the prior year period due to growth in written premium in the Excess Casualty underwriting division, which has a higher percentage of ceded premium than our other divisions.
The net premium retention for the Specialty Admitted Insurance segment increased for the three months ended March 31, 2021 as compared to the prior year primarily due to higher retentions in the fronting business. The net retention on the segment’s fronting business was 15.8% and 9.6% for the three months ended March 31, 2021 and 2020, respectively, while the net retention on the individual risk workers’ compensation business was 27.7% and 29.3%.
The net premium retention for the Casualty Reinsurance segment increased for the three months ended March 31, 2021 as compared to the prior year period due to the higher gross written premiums in the current year and the impact of one retrocessional treaty/fronting arrangement under which 100% of the premiums are ceded. Ceded written premiums under the treaty were $20.7 million in the first quarter of 2021 compared to $15.8 million in the first quarter of 2020.
Underwriting Results
The following table compares our combined ratios by segment:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
Excess and Surplus Lines | | | | | 232.7 | % | | 91.9 | % |
Specialty Admitted Insurance | | | | | 92.3 | % | | 107.4 | % |
Casualty Reinsurance | | | | | 105.3 | % | | 99.4 | % |
Total | | | | | 199.2 | % | | 100.6 | % |
Excess and Surplus Lines Segment
Results for the Excess and Surplus Lines segment are as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) |
Gross written premiums | | | | | | | $ | 181,358 | | | $ | 136,197 | | | 33.2 | % |
Net written premiums | | | | | | | $ | 108,433 | | | $ | 92,206 | | | 17.6 | % |
Net earned premiums | | | | | | | $ | 113,708 | | | $ | 99,739 | | | 14.0 | % |
Losses and loss adjustment expenses | | | | | | | (241,742) | | | (65,529) | | | 268.9 | % |
Underwriting expenses | | | | | | | (22,912) | | | (26,098) | | | (12.2) | % |
Underwriting (loss) profit (1), (2) | | | | | | | $ | (150,946) | | | $ | 8,112 | | | — | |
Ratios: | | | | | | | | | | | |
Loss ratio | | | | | | | 212.6 | % | | 65.7 | % | | |
Expense ratio | | | | | | | 20.1 | % | | 26.2 | % | | |
Combined ratio | | | | | | | 232.7 | % | | 91.9 | % | | |
Accident year loss ratio | | | | | | | 64.3 | % | | 65.7 | % | | |
(1)Underwriting (Loss) Profit is a non-GAAP Measure. See “Reconciliation of Non-GAAP Measures” for a reconciliation to loss before tax and for additional information.
(2)Underwriting results for the three months ended March 31, 2020 include gross fee income of $1.3 million related to Rasier, a former commercial auto account (none for the three months ended March 31, 2021).
The loss ratio of 212.6% for the three months ended March 31, 2021 includes $168.7 million of net adverse reserve development (148.3 percentage points) in our loss estimates for prior accident years, including $170.0 million of net adverse development on commercial auto business that was almost entirely related to a previously canceled account that has been runoff since 2019. The reported losses on this terminated commercial auto account meaningfully exceeded our expectations for the three months ended March 31, 2021. We had expected that reported losses would decline as the account moved further into runoff, but the continued heavy reported loss emergence in the first quarter of 2021 indicated more inherent severity than anticipated. In response, we meaningfully adjusted our actuarial methodology, resulting in a significant strengthening of reserves for this account at March 31, 2021. In prior quarters, our actuarial work for this terminated commercial auto account had been based on industry data, pricing data, experience data, average claims severity data, and blended methodologies. However, the continuation of the highly elevated reported losses in the first quarter of 2021 led us to conclude that using only our own loss experience in our paid and incurred reserve projections rather than the array of inputs that we had used in prior quarters, and giving greater weight to incurred methods, would give us a better estimate of ultimate losses on the this account. The loss ratio of 65.7% for the three months ended March 31, 2020 includes $3,000 of net favorable reserve development in our loss estimates for prior accident years.
The expense ratio for this segment decreased from 26.2% for the three months ended March 31, 2020 to 20.1% for the three months ended March 31, 2021 due to an increase of 16.4% in the Core E&S net earned premiums of the Excess and
Surplus Lines segment including in lines that have meaningful ceding commissions. Gross fee income related to a former commercial auto account contributed to a reduction in the expense ratio of 1.3 percentage points for the three months ended March 31, 2020 (none for the three months ended March 31, 2021).
As a result of the items discussed above, the underwriting results of the Excess and Surplus Lines segment declined from an underwriting profit of $8.1 million for the three months ended March 31, 2020 to an underwriting loss of $150.9 million for the three months ended March 31, 2021.
Specialty Admitted Insurance Segment
Results for the Specialty Admitted Insurance segment are as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) |
Gross written premiums | | | | | | | $ | 127,036 | | | $ | 102,802 | | | 23.6 | % |
Net written premiums | | | | | | | $ | 22,005 | | | $ | 13,356 | | | 64.8 | % |
Net earned premiums | | | | | | | $ | 16,357 | | | $ | 13,283 | | | 23.1 | % |
Losses and loss adjustment expenses | | | | | | | (10,742) | | | (9,905) | | | 8.5 | % |
Underwriting expenses | | | | | | | (4,349) | | | (4,366) | | | (0.4) | % |
Underwriting profit (loss) (1), (2) | | | | | | | $ | 1,266 | | | $ | (988) | | | — | |
Ratios: | | | | | | | | | | | |
Loss ratio | | | | | | | 65.7 | % | | 74.6 | % | | |
Expense ratio | | | | | | | 26.6 | % | | 32.8 | % | | |
Combined ratio | | | | | | | 92.3 | % | | 107.4 | % | | |
Accident year loss ratio | | | | | | | 71.8 | % | | 82.2 | % | | |
(1)Underwriting Profit (Loss) is a non-GAAP Measure. See “Reconciliation of Non-GAAP Measures” for a reconciliation to income (loss) before tax and for additional information.
(2)Underwriting results include gross fee income of $5.1 million and $4.2 million for the three months ended March 31, 2021 and 2020, respectively.
The loss ratios of 65.7% and 74.6% for the three months ended March 31, 2021 and 2020, respectively, include $1.0 million and $1.0 million (6.1 and 7.6 percentage points), respectively, of net favorable development in our loss estimates for prior accident years. The favorable reserve development for both periods reflects the fact that actual loss emergence of the workers’ compensation book has been better than expected.
The expense ratio of the Specialty Admitted Insurance segment was 26.6% for the three months ended March 31, 2021 compared to the prior year ratio of 32.8%. The improvement was driven by the growth in net earned premiums and higher fee income, which increased 21.8% over the prior year due to the growth in our fronting business.
Underwriting results for the Specialty Admitted Insurance segment in the three months ended March 31, 2020 were negatively impacted by higher reported losses on involuntary assigned risk pools for workers' compensation and an accrual for ceded minimum premium on one fronting arrangement, resulting in an additional 7.0 combined ratio points.
As a result of the items discussed above, the Specialty Admitted Insurance segment had an underwriting profit of $1.3 million for the three months ended March 31, 2021 compared to an underwriting loss of $988,000 for the three months ended March 31, 2020.
Casualty Reinsurance Segment
Results for the Casualty Reinsurance segment are as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended March 31, | | % |
| | | | | | | 2021 | | 2020 | | Change |
| | | | | | | ($ in thousands) |
Gross written premiums | | | | | | | $ | 64,861 | | | $ | 44,842 | | | 44.6 | % |
Net written premiums | | | | | | | $ | 44,161 | | | $ | 29,092 | | | 51.8 | % |
Net earned premiums | | | | | | | $ | 30,528 | | | $ | 32,896 | | | (7.2) | % |
Losses and loss adjustment expenses | | | | | | | (21,016) | | | (21,422) | | | (1.9) | % |
Underwriting expenses | | | | | | | (11,137) | | | (11,267) | | | (1.2) | % |
Underwriting (loss) profit (1) | | | | | | | $ | (1,625) | | | $ | 207 | | | — | |
Ratios: | | | | | | | | | | | |
Loss ratio | | | | | | | 68.8 | % | | 65.1 | % | | |
Expense ratio | | | | | | | 36.5 | % | | 34.3 | % | | |
Combined ratio | | | | | | | 105.3 | % | | 99.4 | % | | |
Accident year loss ratio | | | | | | | 60.7 | % | | 59.4 | % | | |
(1)Underwriting (Loss) Profit is a non-GAAP Measure. See “Reconciliation of Non-GAAP Measures” for a reconciliation to loss before tax and for additional information.
The Casualty Reinsurance segment focuses on lower volatility, proportional reinsurance which requires larger ceding commissions resulting in a higher commission expense than in our other segments.
The loss ratios of 68.8% and 65.1% for the three months ended March 31, 2021 and 2020, respectively, include $2.5 million and $1.9 million (8.1 and 5.7 percentage points), respectively, of net adverse development in our loss estimates for prior accident years.
The expense ratio of the Casualty Reinsurance segment was 36.5% and 34.3% for the three months ended March 31, 2021 and 2020, respectively. Commission slide adjustments related to incurred losses increased the expense ratio by 3.2 points in the three months ended March 31, 2021, but decreased the expense ratio by 2.0 points in the three months ended March 31, 2020.
As a result of the items discussed above, underwriting results for the Casualty Reinsurance segment declined from an underwriting profit of $207,000 for the three months ended March 31, 2020 to an underwriting loss of $1.6 million for the three months ended March 31, 2021.
Reserves
An indicator of reserve strength that we monitor closely is the percentage of our gross and net loss reserves that are comprised of incurred but not reported (“IBNR”) reserves.
The Company’s gross reserve for losses and loss adjustment expenses at March 31, 2021 was $2,413.8 million. Of this amount, 60.4% relates to amounts that are IBNR. This amount was 58.7% at December 31, 2020. The Company’s gross reserves for losses and loss adjustment expenses by segment are summarized as follows:
| | | | | | | | | | | | | | | | | |
| Gross Reserves at March 31, 2021 |
| Case | | IBNR | | Total |
| ($ in thousands) |
Excess and Surplus Lines | $ | 566,843 | | | $ | 908,942 | | | $ | 1,475,785 | |
Specialty Admitted Insurance | 255,287 | | | 366,829 | | | 622,116 | |
Casualty Reinsurance | 133,268 | | | 182,677 | | | 315,945 | |
Total | $ | 955,398 | | | $ | 1,458,448 | | | $ | 2,413,846 | |
At March 31, 2021, the amount of net reserves prior to the $335,000 allowance for uncollectible reinsurance recoverables of $1,534.8 million that related to IBNR was 57.9%. This amount was 55.3% at December 31, 2020. The Company’s net reserves for losses and loss adjustment expenses by segment are summarized as follows:
| | | | | | | | | | | | | | | | | |
| Net Reserves at March 31, 2021 |
| Case | | IBNR | | Total |
| ($ in thousands) |
Excess and Surplus Lines | $ | 476,593 | | | $ | 657,103 | | | $ | 1,133,696 | |
Specialty Admitted Insurance | 38,549 | | | 56,335 | | | 94,884 | |
Casualty Reinsurance | 131,142 | | | 175,057 | | | 306,199 | |
Total | $ | 646,284 | | | $ | 888,495 | | | $ | 1,534,779 | |
Other Operating Expenses
In addition to the underwriting, acquisition, and insurance expenses of the Excess and Surplus Lines segment, the Specialty Admitted Insurance segment, and the Casualty Reinsurance segment discussed previously, other operating expenses also include the expenses of the Corporate and Other segment.
Corporate and Other Segment
Other operating expenses for the Corporate and Other segment include personnel costs associated with the Bermuda and U.S. holding companies, professional fees, and various other corporate expenses that are included in our calculation of our expense ratio and our combined ratio. Other operating expenses of the Corporate and Other segment represent the expenses of both the Bermuda and U.S. holding companies that were not reimbursed by our subsidiaries, including costs associated with our internal quota share, rating agencies and strategic initiatives. These costs vary from period-to-period based on the status of these initiatives.
Total operating expenses of the Corporate and Other segment were $8.1 million and $8.3 million for the three months ended March 31, 2021 and 2020, respectively.
Investing Results
Net investment income was $15.1 million and $20.8 million for the three months ended March 31, 2021 and 2020, respectively. The Company's private investments generated income of $334,000 for the three months ended March 31, 2021 compared to income of $517,000 in the respective prior year period. Excluding private investments, our net investment income for the three months ended March 31, 2021 decreased 27.4% from the prior year principally due to lower investment income from bank loan participations resulting from a smaller portfolio and lower investment yields. The average duration of our fixed maturity portfolio was 4.3 years at March 31, 2021.
Major categories of the Company’s net investment income are summarized as follows:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | ($ in thousands) |
Fixed maturity securities | | | | | $ | 11,546 | | | $ | 11,074 | |
Bank loan participations | | | | | 2,873 | | | 4,148 | |
Equity securities | | | | | 1,210 | | | 1,166 | |
Other invested assets: | | | | | | | |
Renewable energy investments | | | | | (681) | | | 1,000 | |
Other private investments | | | | | 1,015 | | | (483) | |
| | | | | 334 | | | 517 | |
Cash, cash equivalents, restricted cash equivalents and short-term investments | | | | | 105 | | | 5,159 | |
Gross investment income | | | | | 16,068 | | | 22,064 | |
Investment expense | | | | | (979) | | | (1,228) | |
Net investment income | | | | | $ | 15,089 | | | $ | 20,836 | |
The following table summarizes our investment returns:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
Annualized gross investment yield on: | | | | | | | |
Average cash and invested assets | | | | | 2.7 | % | | 3.2 | % |
Average fixed maturity securities | | | | | 3.0 | % | | 3.4 | % |
Of our total cash and invested assets of $2,342.5 million at March 31, 2021 (excluding restricted cash equivalents), $183.5 million represents the cash and cash equivalents portion of the portfolio. The majority of the portfolio, or $1,800.2 million, is comprised of fixed maturity securities that are classified as available-for-sale and carried at fair value with unrealized gains and losses on these securities reported, net of applicable taxes, as a separate component of accumulated comprehensive income. Also included in our investments are $160.9 million of bank loan participations, $90.9 million of equity securities, $51.2 million of short-term investments, and $55.9 million of other invested assets.
In connection with the adoption of ASU 2016-13 on January 1, 2020, the Company elected the fair value option in accounting for its portfolio of bank loan participations. Under the fair value option, bank loan participations are measured at fair value, and changes in unrealized gains and losses in bank loan participations are reported in our income statement as net realized and unrealized gains (losses) on investments.
Bank loan participations generally provide a higher yield than our portfolio of fixed maturity securities and are primarily senior, secured floating-rate debt rated “BB”, “B”, or “CCC” by Standard & Poor’s or an equivalent rating from another nationally recognized statistical rating organization, and are therefore below investment grade. Bank loans include assignments of and participations in, performing and non-performing senior corporate debt generally acquired through primary bank syndications and in secondary markets. They consist of, but are not limited to, term loans, the funded and unfunded portions of revolving credit loans, and similar loans and investments. At March 31, 2021 and December 31, 2020, the fair market value of these securities was $160.9 million and $147.6 million, respectively.
For the three months ended March 31, 2021, the Company recognized net realized and unrealized investment gains of $6.3 million, including $3.9 million of net unrealized gains on bank loan participations, $1.7 million of net gains for the change in the fair value of equity securities, $1.0 million of net realized investment gains on the sale of fixed maturity securities, and $372,000 of net realized investment losses on the sale of equity securities.
The outbreak of the coronavirus pandemic in the first quarter of 2020 and uncertainty around the extent of its economic impact caused severe declines in financial markets. For our equity securities and bank loan participations (accounted for at fair value pursuant to the Company's election of the fair value option on January 1, 2020), the declines in fair values led to significant net unrealized losses recognized in earnings. For the three months ended March 31, 2020, the Company recognized net realized and unrealized investment losses of $58.4 million, including $43.9 million of net unrealized losses on bank loan participations, $13.3 million of net unrealized losses for the change in the fair value of equity securities, $1.2 million of net realized investment losses on the sale of bank loan securities, and $214,000 of net realized investment gains on the sale of fixed maturity securities.
In conjunction with its outside investment managers, the Company performs quarterly reviews of all securities within its investment portfolio to determine whether any impairment has occurred. Management concluded that none of its fixed maturity securities were impaired at March 31, 2021 or December 31, 2020. At March 31, 2021, 99.3% of the Company’s fixed maturity security portfolio was rated “BBB-” or better (“investment grade”) by Standard & Poor’s or received an equivalent rating from another nationally recognized rating agency. Management does not intend to sell available-for-sale securities in an unrealized loss position, and it is not “more likely than not” that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs.
The amortized cost and fair value of our available-for-sale fixed maturity securities were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2021 | | December 31, 2020 |
| Cost or Amortized Cost | | Fair Value | | % of Total Fair Value | | Cost or Amortized Cost | | Fair Value | | % of Total Fair Value |
| ($ in thousands) |
Fixed maturity securities, available-for-sale: | | | | | | | | | | | |
State and municipal | $ | 311,053 | | | $ | 319,765 | | | 17.8 | % | | $ | 277,241 | | | $ | 296,405 | | | 16.6 | % |
Residential mortgage-backed | 296,200 | | | 299,956 | | | 16.7 | % | | 286,104 | | | 293,848 | | | 16.5 | % |
Corporate | 737,756 | | | 762,693 | | | 42.4 | % | | 715,145 | | | 766,822 | | | 43.0 | % |
Commercial mortgage and asset-backed | 322,579 | | | 328,180 | | | 18.2 | % | | 314,911 | | | 326,719 | | | 18.3 | % |
| | | | | | | | | | | |
U.S. Treasury securities and obligations guaranteed by the U.S. government | 88,145 | | | 89,557 | | | 4.9 | % | | 97,489 | | | 99,848 | | | 5.6 | % |
| | | | | | | | | | | |
Total fixed maturity securities, available-for-sale | $ | 1,755,733 | | | $ | 1,800,151 | | | 100.0 | % | | $ | 1,690,890 | | | $ | 1,783,642 | | | 100.0 | % |
The following table sets forth the composition of the Company’s portfolio of available-for-sale fixed maturity securities by rating as of March 31, 2021:
| | | | | | | | | | | |
Standard & Poor’s or Equivalent Designation | Fair Value | | % of Total |
| ($ in thousands) |
AAA | $ | 354,813 | | | 19.7 | % |
AA | 674,120 | | | 37.4 | % |
A | 553,765 | | | 30.8 | % |
BBB | 205,559 | | | 11.4 | % |
Below BBB and unrated | 11,894 | | | 0.7 | % |
Total | $ | 1,800,151 | | | 100.0 | % |
At March 31, 2021, our portfolio of fixed maturity securities contained corporate fixed maturity securities (available-for-sale) with a fair value of $762.7 million. A summary of these securities by industry segment is shown below as of March 31, 2021:
| | | | | | | | | | | |
Industry | Fair Value | | % of Total |
| ($ in thousands) |
Industrials and Other | $ | 191,607 | | | 25.1 | % |
Financial | 194,057 | | | 25.4 | % |
Consumer Discretionary | 102,813 | | | 13.5 | % |
Health Care | 89,697 | | | 11.8 | % |
Consumer Staples | 68,739 | | | 9.0 | % |
Utilities | 115,780 | | | 15.2 | % |
Total | $ | 762,693 | | | 100.0 | % |
Corporate fixed maturity securities (available-for-sale) include publicly traded securities and privately placed bonds as shown below as of March 31, 2021:
| | | | | | | | | | | |
Public/Private | Fair Value | | % of Total |
| ($ in thousands) |
Publicly traded | $ | 686,860 | | | 90.1 | % |
Privately placed | 75,833 | | | 9.9 | % |
Total | $ | 762,693 | | | 100.0 | % |
The amortized cost and fair value of our available-for-sale investments in fixed maturity securities summarized by contractual maturity are as follows:
| | | | | | | | | | | | | | | | | |
| March 31, 2021 |
| Amortized Cost | | Fair Value | | % of Total Value |
| ($ in thousands) |
Due in: | | | | | |
One year or less | $ | 110,269 | | | $ | 111,427 | | | 6.2 | % |
After one year through five years | 455,605 | | | 477,392 | | | 26.5 | % |
After five years through ten years | 327,033 | | | 332,488 | | | 18.5 | % |
After ten years | 244,047 | | | 250,708 | | | 13.9 | % |
Residential mortgage-backed | 296,200 | | | 299,956 | | | 16.7 | % |
Commercial mortgage and asset-backed | 322,579 | | | 328,180 | | | 18.2 | % |
| | | | | |
Total | $ | 1,755,733 | | | $ | 1,800,151 | | | 100.0 | % |
At March 31, 2021, the Company had no investments in securitizations of alternative-A mortgages or sub-prime mortgages.
Interest Expense
Interest expense was $2.2 million and $2.9 million for the three months ended March 31, 2021 and 2020, respectively. See “—Liquidity and Capital Resources—Sources and Uses of Funds” for more information regarding our senior bank debt facilities and trust preferred securities.
Amortization of Intangibles
The Company recorded $91,000 and $149,000 of amortization of intangible assets for each of the three months ended March 31, 2021 and 2020, respectively.
Income Tax Expense
Our effective tax rate fluctuates from period to period based on the relative mix of income reported by country and the respective tax rates imposed by each tax jurisdiction. For U.S.-sourced income, the Company’s U.S. federal income tax expense differs from the amounts computed by applying the federal statutory income tax rate to income before taxes due primarily to interest income on tax-advantaged state and municipal securities, dividends received income, and excess tax benefits on share based compensation. The Company had a pre-tax loss of $140.8 million for the three months ended March 31, 2021 and recorded a U.S. federal income tax benefit of $37.4 million. The pre-tax loss was largely driven by the $170.1 million of net adverse reserve development on prior accident years, including $168.7 million of net adverse development from the Excess and Surplus Lines segment that was primarily related to a former commercial auto account. For the three months ended March 31, 2021, our U.S. federal income tax benefit was 26.5% of the loss before taxes. The outbreak of the coronavirus pandemic in the
first quarter of 2020 led to significant unrealized losses in our investment portfolio that were recognized in earnings. As a result, the Company had a pre-tax loss of $41.2 million for the three months ended March 31, 2020 and recorded a U.S. federal income tax benefit of $4.4 million. For the three months ended March 31, 2020, our U.S. federal income tax benefit was 10.7% of the loss before taxes. The change in effective tax rate for the two periods reflects changes in reserve estimates between accident years in the commercial auto business, and the related impact on the mix of income reported by country in those respective periods.
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Funds
Dividends
We are organized as a Bermuda holding company with our operations conducted by our wholly-owned subsidiaries. Accordingly, our holding company may receive cash through loans from banks, issuance of common shares, borrowings on our credit facilities, corporate service fees or dividends received from our subsidiaries, and/or other transactions. Our U.S. holding company may receive cash in a similar manner and also through payments from our subsidiaries pursuant to our U.S. consolidated tax allocation agreement.
The payment of dividends by our subsidiaries to us is limited by statute. In general, the laws and regulations applicable to our domestic insurance subsidiaries limit the aggregate amount of dividends or other distributions that they may declare or pay within any 12-month period without advance regulatory approval. Generally, the limitations are based on the greater of statutory net income for the preceding year or 10.0% of statutory surplus at the end of the preceding year. James River paid a $17.0 million dividend to the U.S. holding company in the three months ended March 31, 2021, reducing the maximum amount of dividends available to the U.S. holding company from our U.S. insurance subsidiaries during the remainder of 2021 without regulatory approval to $11.6 million. However, insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels and could refuse to permit the payment of dividends calculated under any applicable formula.
The Bermuda Insurance Act of 1978 prohibits an insurer from declaring or paying a dividend if it is in breach of its minimum solvency margin, its enhanced capital requirement, or its minimum liquidity ratio, or if the declaration or payment of such dividend would cause such a breach. An insurer can declare or pay dividends without prior regulatory approval up to 25% of the total statutory capital and surplus. The maximum combined amount of dividends and return of capital available to us from our Bermuda insurers in 2021 is calculated to be approximately $153.8 million. However, any dividend payment is contingent upon continued compliance with Bermuda regulatory requirements, including but not limited to the enhanced solvency requirement calculations.
At March 31, 2021, the Bermuda holding company had $5.3 million of cash and cash equivalents. The U.S. holding company had $57.1 million of cash and invested assets, comprised of cash and cash equivalents of $10.1 million and other invested assets of $47.0 million, which are not subject to regulatory restrictions. Additionally, our U.K. intermediate holding company had no invested assets and cash of less than ten thousand dollars at March 31, 2021.
Credit Agreements
The Company has a $315.0 million senior revolving credit facility (as amended or amended and restated, the “2013 Facility”). The 2013 Facility is comprised of the following at March 31, 2021:
•A $102.5 million secured revolving facility used by JRG Re to issue letters of credit for the benefit of third-party reinsureds. This portion of our credit facility is secured by our investment securities. At March 31, 2021, the Company had $89.7 million of letters of credit issued under the secured facility.
•A $212.5 million unsecured revolving facility to meet the working capital needs of the Company. All unpaid principal on the revolver is due at maturity. Interest accrues quarterly and is payable in arrears at 3-month LIBOR plus a margin which is currently 1.625% and is subject to change according to terms in the credit agreement. At March 31, 2021, the Company had a drawn balance of $185.8 million outstanding on the unsecured revolver.
The 2013 Facility has been amended from time to time since its inception in 2013. On November 8, 2019, the Company entered into a Second Amended and Restated Credit Agreement for the 2013 Facility which, among other things, extended the maturity date of the 2013 Facility until November 8, 2024, increased the amount available under the unsecured revolving credit facility to $212.5 million, lowered the applicable interest rate and letter of credit fees, and modified certain negative covenants to be less restrictive.
The 2013 Facility contains certain financial and other covenants (including minimum net worth, maximum ratio of total adjusted debt outstanding to total capitalization, and financial strength ratings) with which the Company was in compliance at March 31, 2021.
On August 2, 2017, the Company, and its wholly-owned subsidiary, JRG Re, together as borrowers, entered into a credit agreement (the "2017 Facility") that provides the Company with a revolving line of credit of up to $100.0 million, which may be used for loans and letters of credit made or issued, at the borrowers' option, on a secured or unsecured basis. Obligations under the 2017 Facility carry a variable rate of interest subject to terms in the credit agreement and will mature 30 days after notice of termination from the lender. The 2017 Facility contains certain financial and other covenants with which we are in compliance at March 31, 2021. The loans and letters of credit made or issued under the revolving line of credit of the 2017 Facility may be used to finance the borrowers' general corporate purposes. On November 8, 2019, the Company entered into a First Amendment to Credit Agreement which, among other things, lowered the applicable interest rate and modified certain negative covenants to be less restrictive. Interest accrues quarterly and is payable in arrears at variable rates which are subject to change according to terms in the credit agreement. At March 31, 2021, unsecured loans of $61.5 million and secured letters of credit totaling $15.2 million were outstanding on the 2017 Facility.
On May 26, 2004, we issued $15.0 million of senior debt due April 29, 2034. The senior debt is not redeemable by the holder or subject to sinking fund requirements. Interest accrues quarterly and is payable in arrears at a floating rate per annum equal to the 3-month LIBOR plus 3.85%. This senior debt is redeemable at par prior to its stated maturity at our option in whole or in part. The terms of the senior debt contain certain covenants, with which we are in compliance at March 31, 2021, and which, among other things, restrict our ability to assume senior indebtedness secured by our U.S. holding company’s common stock or its subsidiaries’ capital stock or to issue shares of its subsidiaries’ capital stock.
From May 2004 through January 2008, we sold trust preferred securities through five Delaware statutory trusts sponsored and wholly-owned by the Company or its subsidiaries. Each trust used the net proceeds from the sale of its trust preferred securities to purchase our floating-rate junior subordinated debt.
The following table summarizes the nature and terms of the junior subordinated debt and trust preferred securities outstanding at March 31, 2021 (including the Company’s repurchases of a portion of these trust preferred securities):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| James River Capital Trust I | | James River Capital Trust II | | James River Capital Trust III | | James River Capital Trust IV | | Franklin Holdings II (Bermuda) Capital Trust I |
| ($ in thousands) |
Issue date | May 26, 2004 | | December 15, 2004 | | June 15, 2006 | | December 11, 2007 | | January 10, 2008 |
Principal amount of trust preferred securities | $7,000 | | $15,000 | | $20,000 | | $54,000 | | $30,000 |
Principal amount of junior subordinated debt | $7,217 | | $15,464 | | $20,619 | | $55,670 | | $30,928 |
Carrying amount of junior subordinated debt net of repurchases | $7,217 | | $15,464 | | $20,619 | | $44,827 | | $15,928 |
Maturity date of junior subordinated debt, unless accelerated earlier | May 24, 2034 | | December 15, 2034 | | June 15, 2036 | | December 15, 2037 | | March 15, 2038 |
Trust common stock | $217 | | $464 | | $619 | | $1,670 | | $928 |
Interest rate, per annum | Three-Month LIBOR plus 4.0% | | Three-Month LIBOR plus 3.4% | | Three-Month LIBOR plus 3.0% | | Three-Month LIBOR plus 3.1% | | Three-Month LIBOR plus 4.0% |
All of the junior subordinated debt is currently redeemable at 100.0% of the unpaid principal amount at our option.
The junior subordinated debt contains certain covenants with which we are in compliance as of March 31, 2021.
At March 31, 2021 and December 31, 2020, the Company's leverage ratio was 35.0% and 30.4%, respectively. The leverage ratio is defined in our senior credit agreements as the ratio of adjusted consolidated debt to total capital. Adjusted consolidated debt treats trust preferred securities as equity capital up to 15% of total capital. Total capital is defined as total debt plus tangible equity excluding accumulated other comprehensive income. Having debt as part of our capital structure allows us to generate a higher return on equity and greater book value per share results than we could by using equity capital alone.
Ceded Reinsurance
Our insurance segments enter into reinsurance contracts to limit our exposure to potential losses arising from large risks, to protect against the aggregation of several risks in a common loss occurrence, and to provide additional capacity for growth. Our reinsurance is contracted under excess of loss and quota share reinsurance contracts. In excess of loss reinsurance, the reinsurer agrees to assume all or a portion of the ceding company’s losses in excess of a specified amount. The premiums payable to the reinsurer are negotiated by the parties based on their assessment of the amount of risk being ceded to the reinsurer because the
reinsurer does not share proportionately in the ceding company’s losses. In quota share reinsurance, the reinsurer agrees to assume a specified percentage of the ceding company’s losses arising out of a defined class of business in exchange for a corresponding percentage of premiums. For the three months ended March 31, 2021 and 2020, our net premium retention was 46.8% and 47.4%, respectively.
The following is a summary of our Excess and Surplus Lines segment’s net retention after reinsurance as of March 31, 2021:
| | | | | | | | |
| | Company Retention |
| | |
Casualty | | |
Primary Specialty Casualty, including Professional Liability | | Up to $1.0 million per occurrence, subject to a $1.0 million aggregate deductible. (1) |
Primary Casualty | | Up to $2.0 million per occurrence. (2) |
Excess Casualty | | Up to $1.0 million per occurrence. (3) |
Property | | Up to $5.0 million per event. (4) |
(1)Except for Life Sciences quota share carve out, which is up to $2.0 million per occurrence
(2)Total exposure to any one claim is generally $1.0 million.
(3)For policies with an occurrence limit up to $10.0 million, the excess casualty treaty is set such that our retention is no more than $1.0 million.
(4)The property catastrophe reinsurance treaty has a limit of $40.0 million with one reinstatement.
We use catastrophe modeling software to analyze the risk of severe losses from hurricanes and earthquakes on our exposure. We utilize the model in our risk selection, pricing, and to manage our overall portfolio probable maximum loss (“PML”) accumulations. A PML is an estimate of the amount we would expect to pay in any one catastrophe event within a given annual probability of occurrence (i.e. a return period or loss exceedance probability).
In our Excess and Surplus Lines segment, we write a small book of excess property insurance, but we do not write primary property insurance. The Excess and Surplus Lines segment has a surplus share reinsurance treaty in effect that was specifically designed to cover property risks. The surplus share treaty along with facultative reinsurance helps ensure that our net retained limit per risk will be $5.0 million or less.
Based upon the modeling of our Excess and Surplus Lines and Specialty Admitted segments, it would take an event beyond our 1 in 1000 year PML to exhaust our $45.0 million property catastrophe treaty. In the event of a catastrophe loss exhausting our $45.0 million property catastrophe treaty, we estimate our pre-tax cost at approximately $7.3 million, including reinstatement premiums and net retentions. In addition to this retention, we would retain any losses in excess of our reinsurance coverage limits.
We could enter into a transaction to transfer the risks associated with all or part of our commercial auto business. It is uncertain whether we will enter into any such transaction, or the terms of any such transaction should one be consummated.
The following is a summary of our Specialty Admitted Insurance segment’s ceded reinsurance in place as of March 31, 2021:
| | | | | | | | |
Line of Business | | Coverage |
Casualty | | |
Workers’ Compensation | | Quota share coverage for 70-85% of the first $1.0 million.(1)(2) Excess of loss coverage for $29.0 million in excess of $1.0 million.(1)(2) |
Auto Programs | | Quota share coverage for 70-90% of limits up to $1.5 million liability and $5.0 million physical damage per occurrence. |
General Liability & Professional Liability – Programs | | Quota share coverage for 70% - 100% of limits up to $3.0 million per occurrence. |
Umbrella and Excess Casualty - Programs | | Quota share coverage for 95%-100% of limits up to $10.0 million per occurrence, and excess of loss coverage for $5.0 million in excess of $10.0 million. |
Property | | |
Property within Package - Programs | | Quota share coverage for 100% of limits up to $25.0 million per occurrence. (3) |
Excess Property | | Quota share coverage for 100% of limits up to $16.9 million. |
Catastrophe Coverage | | Excess of Loss coverage for $44.0 million in excess of $1.0 million per occurrence. |
Aviation Programs | | Quota share coverage for 80% of limits up to $20 million liability and $2.5 million hull per occurrence, each aircraft; and excess of loss coverage for up to $7.3M excess of $200 thousand of our 20% share of the quota share each occurrence. |
(1) Excluding one program which has quota share coverage for 81.25% of the first $1.0 million per occurrence and excess of loss coverage for $49.0 million in excess of $1.0 million per occurrence.
(2) Includes any residual market pools.
(3) Excluding one program which has a reinsurance coverage for 90% of the first $500,000 and excess of loss coverage for $39.5 million in excess of $500,000 per risk per occurrence.
Our Specialty Admitted Insurance segment purchases reinsurance for at least 50% of the exposed limits on specialty admitted property-casualty business. The segment enters into reinsurance contracts for the individual risk workers’ compensation business as well as fronting and program business. While the segment focuses on casualty business, incidental property risk is incurred in the fronting and program business. The segment is covered for $44.0 million in excess of $1.0 million per occurrence to manage its property exposure to an approximate 1 in 1,000 year PML.
In our Casualty Reinsurance segment, we also have limited property catastrophe exposure, primarily through auto physical damage coverage. In the aggregate, we believe our pre-tax group-wide PML from a 1 in 1,000 year property catastrophe event would not exceed $10.0 million, inclusive of reinstatement premiums payable.
We also have a clash and contingency reinsurance treaty to cover both the Excess and Surplus Lines and Specialty Admitted Insurance segments in the event of a claims incident involving more than one of our insureds. The treaty covers $10.0 million in excess of a $2.0 million retention for loss occurrences within the treaty term. This coverage has two reinstatements in the event we exhaust any of the coverage. As of March 31, 2021, our average net retained limit per risk is $2.5 million.
Effective January 1, 2020, we purchased an additional $10.0 million in claims made coverage for excess policy limits and extra contractual obligations exposures above the clash and contingency treaty for the period 2014 to present. This treaty has one reinstatement.
The Company’s insurance segments remain liable to policyholders if its reinsurers are unable to meet their contractual obligations under applicable reinsurance agreements. We establish an allowance for credit losses for our current estimate of uncollectible reinsurance recoverables. At March 31, 2021, the allowance for credit losses on reinsurance recoverables was $335,000. To minimize exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk. The Company generally seeks to purchase reinsurance from reinsurers with A.M. Best financial strength ratings of “A-” (Excellent) or better. The Company’s reinsurance contracts generally require reinsurers that are not authorized as reinsurers under U.S. state insurance regulations or that experience rating downgrades from rating agencies below specified levels to fund their share of the Company’s ceded outstanding losses and loss adjustment expense reserves, typically through the use of irrevocable and unconditional letters of credit. In fronting arrangements, which the Company conducts through its Specialty Admitted Insurance segment, we are subject to credit risk
with regard to insurance companies who act as reinsurers for us in such arrangements. We customarily require a collateral trust arrangement to secure the obligations of the insurance entity for whom we are fronting.
At March 31, 2021, we had reinsurance recoverables on unpaid losses of $878.7 million and reinsurance recoverables on paid losses of $42.6 million, and all material recoverable amounts were from companies with A.M. Best ratings of “A-” or better, collateral had been posted by the reinsurer for our benefit, or represent recoverables from a state residual market for automobile insurance.
Amounts Recoverable from an Indemnifying Party
The Company previously issued a set of insurance contracts to Rasier under which the Company pays losses and loss adjustment expenses on the contracts. The Company has indemnity agreements with Rasier (non-insurance entities) and is contractually entitled to receive reimbursement for a significant portion of the losses and loss adjustment expenses paid on behalf of Rasier and other expenses incurred by the Company. Rasier is required to collateralize all amounts currently due to the Company and to provide additional collateral sufficient to cover the amounts that may be recoverable under the indemnity agreements, including, among other things, case loss and loss adjustment expense reserves, IBNR loss and loss adjustment expense reserves, extra contractual obligations and excess of policy limits liabilities. The collateral is provided through a collateral trust arrangement established in favor of the Company by a captive insurance company affiliate of Rasier.
As permitted under our indemnification agreements with Rasier and the associated trust agreement, we have withdrawn the collateral posted to the trust account. At March 31, 2021, the Company held collateral funds of $751.7 million. The funds withdrawn from the trust account, currently invested in short term securities and included in restricted cash equivalents on the Company's consolidated balance sheet, will be used to reimburse the Company for the losses and loss adjustment expenses paid on behalf of Rasier and other related expenses incurred by the Company to the extent not paid as required under the indemnity agreements.
The Company has ongoing exposure to estimated losses and expenses on these contracts growing at a faster pace than growth in our collateral balances. In addition, we have credit exposure if our estimates of future losses and loss adjustment expenses and other amounts recoverable, which are the basis for establishing collateral balances, are lower than actual amounts paid or payable. The amount of our credit exposure in any of these instances could be material. To mitigate these risks, we closely and frequently monitor our exposure compared to our collateral held, and we request additional collateral when our analysis indicates that we have uncollateralized exposure.
Cash Flows
Our sources of funds consist primarily of premiums written, investment income, reinsurance recoveries, proceeds from sales and redemptions of investments, borrowings on our credit facilities, and the issuance of common shares. We use operating cash flows primarily to pay operating expenses, losses and loss adjustment expenses, reinsurance premiums, and income taxes. The following table summarizes our cash flows:
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| ($ in thousands) |
Cash, cash equivalents, and restricted cash equivalents (used in) provided by: | | | |
Operating activities | $ | (81,005) | | | $ | (65,305) | |
Investing activities | 5,988 | | | (49,721) | |
Financing activities | (12,004) | | | 107,494 | |
Change in cash, cash equivalents, and restricted cash equivalents | $ | (87,021) | | | $ | (7,532) | |
Cash used in operating activities for the three months ended March 31, 2021 and 2020, respectively, primarily reflects $108.3 million and $91.8 million of restricted cash equivalents returned to a former insured per the terms of a collateral trust (see Amounts Recoverable from an Indemnifying Party above). Excluding the reduction in the collateral funds, cash provided by operating activities was $27.2 million and $26.5 million for the three months ended March 31, 2021 and 2020, respectively. Cash provided by operating activities excluding restricted cash equivalents for the three months ended March 31, 2021 and 2020 primarily reflects growth in our U.S. segments and the collection of premiums receivable at a quicker rate than payments of loss and loss adjustment expenses.
Cash used in investing activities reflects our efforts to enhance the yield in our investment portfolio by investing available cash and cash equivalents into higher yielding investments. Cash and cash equivalents (excluding restricted cash equivalents) comprised 7.8% and 12.9% of total cash and invested assets at March 31, 2021 and 2020, respectively.
Cash (used in)/provided by financing activities for the three months ended March 31, 2021 and 2020 included $9.6 million and $9.5 million of dividends paid to shareholders, respectively. In addition, we drew $119.0 million on our senior credit facilities in the three months ended March 31, 2020 as a precautionary measure to increase our cash position and preserve financial flexibility in light of uncertainty in the global markets resulting from the coronavirus (COVID-19) outbreak.
Ratings
The A.M. Best financial strength rating for our group’s regulated insurance subsidiaries is “A” (Excellent) with a negative outlook. This rating reflects A.M. Best’s opinion of our insurance subsidiaries’ financial strength, operating performance and ability to meet obligations to policyholders and is not an evaluation directed towards the protection of investors. The rating for our operating insurance and reinsurance companies of “A” (Excellent) is the third highest rating of the thirteen ratings issued by A.M. Best and is assigned to insurers that have, in A.M. Best’s opinion, an excellent ability to meet their ongoing obligations to policyholders. On March 4, 2021, A.M. Best announced that it reduced the outlook on our regulated insurance subsidiaries to negative from stable on the “A” (Excellent) financial strength rating on such entities following our announcement of $86.0 million of adverse development on reserves for losses and loss adjustment expenses in the fourth quarter of 2020 principally related to our commercial auto business in our Excess and Surplus Lines segment. In the first quarter of 2021, we experienced $168.7 million of further adverse development on reserves for losses and loss adjustment expenses in our Excess and Surplus Lines segment, inclusive of $170.0 million of unfavorable development in our commercial auto business. Based upon this additional adverse development, we believe that A.M. Best is likely to downgrade our financial strength rating to “A-” (Excellent).
The financial strength ratings assigned by A.M. Best have an impact on the ability of our regulated subsidiaries to attract and retain agents and brokers and on the risk profiles of the submissions for insurance that our subsidiaries receive. The “A” (Excellent) ratings assigned to our insurance and reinsurance subsidiaries are consistent with our business plans and we believe allow our subsidiaries to actively pursue relationships with the agents and brokers identified in their marketing plans.
EQUITY
The Company issued 125,669 common shares in the three months ended March 31, 2021. The new shares were related to stock option exercises and vesting RSUs. The total common shares outstanding increased from 30,649,261 at December 31, 2020 to 30,774,930 at March 31, 2021.
Share Based Compensation Expense
For the three months ended March 31, 2021 and 2020, the Company recognized $1.9 million and $1.9 million of share based compensation expense, respectively. As of March 31, 2021, the Company had $16.2 million of unrecognized share based compensation expense expected to be charged to earnings over a weighted-average period of 2.3 years.
Equity Incentive Plans
Options
The following table summarizes option activity:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Shares | | Weighted- Average Exercise Price | | Shares | | Weighted- Average Exercise Price |
Outstanding: | | | | | | | |
Beginning of period | 463,324 | | | $ | 32.25 | | | 643,851 | | | $ | 30.41 | |
Granted | — | | | $ | — | | | — | | | $ | — | |
Exercised | (29,884) | | | $ | 26.37 | | | — | | | $ | — | |
Forfeited | — | | | $ | — | | | — | | | $ | — | |
End of period | 433,440 | | | $ | 32.65 | | | 643,851 | | | $ | 30.41 | |
Exercisable, end of period | 433,440 | | | $ | 32.65 | | | 640,606 | | | $ | 30.35 | |
All of the outstanding options vest over three years and have a contractual life of seven years from the original date of grant.
RSUs
The following table summarizes RSU activity:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Shares | | Weighted- Average Grant Date Fair Value | | Shares | | Weighted- Average Grant Date Fair Value |
| | | | | | | |
Unvested, beginning of period | 399,856 | | | $ | 43.59 | | | 340,368 | | | $ | 41.50 | |
Granted | 138,936 | | | $ | 50.24 | | | 179,016 | | | $ | 43.55 | |
Vested | (161,004) | | | $ | 41.89 | | | (142,830) | | | $ | 41.16 | |
Forfeited | (1,089) | | | $ | 42.44 | | | (1,188) | | | $ | 42.07 | |
Unvested, end of period | 376,699 | | | $ | 46.78 | | | 375,366 | | | $ | 42.61 | |
Outstanding RSUs granted to employees vest ratably over a three year vesting period. RSUs granted to non-employee directors have a one year vesting period.
RECONCILIATION OF NON-GAAP MEASURES
Reconciliation of Underwriting Profit
We believe that the disclosure of underwriting profit by individual segment and of the Company as a whole is useful to investors, analysts, rating agencies and other users of our financial information in evaluating our performance because our objective is to consistently earn underwriting profits. We evaluate the performance of our segments and allocate resources based primarily on underwriting profit. Our definition of underwriting profit may not be comparable to that of other companies.
The following table reconciles the underwriting (loss) profit by individual segment and for the entire Company to consolidated income (loss) before U.S. Federal income taxes:
| | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
| | | | | 2021 | | 2020 |
| | | | | (in thousands) |
Underwriting (loss) profit of the insurance segments: | | | | | | | |
Excess and Surplus Lines | | | | | $ | (150,946) | | | $ | 8,112 | |
Specialty Admitted Insurance | | | | | 1,266 | | | (988) | |
Casualty Reinsurance | | | | | (1,625) | | | 207 | |
Total underwriting (loss) profit of insurance segments | | | | | (151,305) | | | 7,331 | |
Other operating expenses of the Corporate and Other segment | | | | | (8,056) | | | (8,279) | |
Underwriting loss (1) | | | | | (159,361) | | | (948) | |
Net investment income | | | | | 15,089 | | | 20,836 | |
Net realized and unrealized gains (losses) on investments | | | | | 6,272 | | | (58,407) | |
Amortization of intangible assets | | | | | (91) | | | (149) | |
Other income and expenses | | | | | (522) | | | 326 | |
Interest expense | | | | | (2,216) | | | (2,876) | |
Loss before income taxes | | | | | $ | (140,829) | | | $ | (41,218) | |
(1)Included in underwriting results for the three months ended March 31, 2021 and 2020 is gross fee income of $5.1 million and $5.5 million, respectively.
Reconciliation of Adjusted Net Operating (Loss) Income
We define adjusted net operating (loss) income as net loss excluding net realized and unrealized gains (losses) on investments, and certain non-operating expenses such as professional service fees related to various strategic initiatives and the filing of registration statements for the offering of securities, and severance costs associated with terminated employees. We use adjusted net operating (loss) income as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted net operating (loss) income should not be viewed as a substitute for net loss calculated in accordance with GAAP, and our definition of adjusted net operating (loss) income may not be comparable to that of other companies.
Our loss before taxes and net loss reconcile to our adjusted net operating (loss) income as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2021 | | 2020 |
| Loss Before Taxes | | Net Loss | | (Loss) Income Before Taxes | | Net (Loss) Income |
| ($ in thousands) |
Loss as reported | $ | (140,829) | | | $ | (103,460) | | | $ | (41,218) | | | $ | (36,815) | |
Net realized and unrealized investment (gains) losses | (6,272) | | | (5,751) | | | 58,407 | | | 52,233 | |
Other expenses | 527 | | | 416 | | | — | | | — | |
Adjusted net operating (loss) income | $ | (146,574) | | | $ | (108,795) | | | $ | 17,189 | | | $ | 15,418 | |
Tangible Equity (per Share) and Pre Dividend Tangible Equity (per Share)
Key financial measures that we use to assess our longer term financial performance include the percentage growth in our tangible equity per share and our return on tangible equity. We believe tangible equity is a good measure to evaluate the strength of our balance sheet and to compare returns relative to this measure. For the three months ended March 31, 2021, our tangible equity per share decreased by 27.3%. Absent the $9.3 million in dividends to shareholders in the three months ended March 31, 2021, our tangible equity per share decreased by 25.7% for the three months ended March 31, 2021.
We define tangible equity as the sum of shareholders’ equity less goodwill and intangible assets (net of amortization). Our definition of tangible equity may not be comparable to that of other companies, and it should not be viewed as a substitute for shareholders’ equity calculated in accordance with GAAP. The following table reconciles shareholders’ equity to tangible equity as of March 31, 2021 and December 31, 2020 and reconciles tangible equity to pre-dividend tangible equity as of March 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2021 | | December 31, 2020 |
| Equity | | Equity per Share | | Equity | | Equity per Share |
| ($ in thousands, except share amounts) |
Shareholders’ equity | $ | 639,628 | | | $ | 20.78 | | | $ | 795,608 | | | $ | 25.96 | |
Less: | | | | | | | |
Goodwill | 181,831 | | | 5.90 | | | 181,831 | | | 5.93 | |
Intangible assets, net | 36,311 | | | 1.18 | | | 36,402 | | | 1.19 | |
Tangible equity | $ | 421,486 | | | $ | 13.70 | | | $ | 577,375 | | | $ | 18.84 | |
Dividends to shareholders for the three months ended March 31, 2021 | 9,343 | | | 0.30 | | | | | |
Pre-dividend tangible equity | $ | 430,829 | | | $ | 14.00 | | | | | |
| | | | | | | |
| | | | | | | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign currency exchange rates and commodity prices. Our consolidated balance sheets include assets and liabilities with estimated fair values that are subject to market risk. Our primary market risks have been interest rate risk associated with investments in fixed maturities and equity price risk associated with investments in equity securities. We do not have material exposure to foreign currency exchange rate risk or commodity risk.
There have been no material changes in market risk from the information provided in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2020.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required financial disclosure. In connection with the preparation of this quarterly report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of our management, including the CEO and CFO, as of March 31, 2021, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of March 31, 2021.
Changes in Internal Controls over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during our quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
The effectiveness of any system of controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that our controls and procedures will detect all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be attained.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We are involved in various legal proceedings, including commercial matters and litigation regarding insurance claims which arise in the ordinary course of business. We believe that the outcome of such matters, individually and in the aggregate, is not reasonably likely to have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Item 1A. Risk Factors
There have been no material changes in our risk factors in the quarter ended March 31, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020, except as follows:
Our financial strength rating is likely to be downgraded, which may have a significant impact on our business, liquidity and financial condition
Companies, insurers and reinsurance brokers use ratings from independent ratings agencies as an important means of assessing the financial strength and quality of reinsurers. A.M. Best Company (“A.M. Best”) assigns ratings that are intended to provide an independent opinion of an insurance or reinsurance company’s ability to meet its obligations to policyholders and such ratings are not an evaluation directed to investors. A.M. Best periodically reviews our rating and may revise it downward at its sole discretion based primarily on its analysis of our balance sheet strength (including capital adequacy and loss and loss adjustment expense reserve adequacy), operating performance and business profile.
On March 4, 2021, A.M. Best announced that it reduced the outlook on our regulated insurance subsidiaries to negative from stable on the “A” (Excellent) financial strength rating on such entities following our announcement of $86.0 million of adverse development on reserves for losses and loss adjustment expenses in the fourth quarter of 2020 principally related to our commercial auto business in our Excess and Surplus Lines segment. In the first quarter of 2021, we experienced $168.7 million of further adverse development on reserves for losses and loss adjustment expenses in our Excess and Surplus Lines segment, inclusive of $170.0 million of unfavorable development in our commercial auto business. Based upon this additional adverse development, we believe that A.M. Best is likely to downgrade our financial strength rating to “A-” (Excellent). A reduction in our financial strength rating may impact our ability to attract and retain insurance and reinsurance business that our subsidiaries write. Further, our competitive position in the industry, and therefore our business, could be adversely affected. The downgrade of our financial strength rating could result in a substantial loss of business, as policyholders might move to other companies with higher financial strength ratings.
Our credit agreements contain a number of financial covenants, the breach of any of which could result in acceleration of payment of our credit facilities.
As of March 31, 2021, we had an outstanding unsecured balance of approximately $247.3 million in the aggregate under our two bank credit agreements. The agreements contain certain financial covenants that require us to maintain consolidated net worth in excess of a specified minimum amount and a leverage ratio as of the end of any fiscal quarter not in excess of 0.35 to 1. The agreements contain other covenants which, among other things, require ongoing compliance with applicable insurance regulations and require each of our regulated insurance subsidiaries to maintain ratings from A.M. Best not lower than an A-. A breach of any of these covenants could result in acceleration of our obligations to repay our outstanding indebtedness under such agreement if we are unable to obtain a waiver or amendment from our lenders, and otherwise could impair our ability to borrow funds or result in higher borrowing costs.
Our actual incurred losses may be greater than our loss and loss adjustment expense reserves, which could have a material adverse effect on our financial condition and results of operations.
Our financial condition and results of operations depend upon our ability to assess accurately the potential losses and loss adjustment expenses under the terms of the insurance policies or reinsurance contracts we underwrite. Reserves do not represent an exact calculation of liability. Rather, reserves represent an estimate of what we expect the ultimate settlement and administration of claims will cost us, and our ultimate liability may be greater or less than current reserves. These estimates are based on our assessment of facts and circumstances then known, as well as estimates of future trends in claim severity, claim frequency, judicial theories of liability and other factors. These variables are affected by both internal and external events that could increase our exposure to losses, including changes in actuarial projections, claims handling procedures, inflation, climate change, economic and judicial trends, and legislative changes. We continually monitor reserves using new information on reported claims and a variety of statistical techniques.
In the insurance and reinsurance industry, there is always the risk that reserves may prove inadequate, and actual results always differ from our reserve estimates. It is possible for insurance and reinsurance companies to underestimate the cost of claims. Our estimates could prove to be low, and this underestimation could have a material adverse effect on our financial strength. For example, in the first quarter of 2021, we experienced $170.1 million of adverse development on reserves for losses and loss adjustment expenses principally relating to the 2019 and prior accident years for the commercial auto business in our Excess and Surplus Lines segment, and in 2020 we experienced $92.2 million of adverse development on reserves for losses and loss adjustment expenses principally relating to the 2018 and prior accident years for the commercial auto business in our Excess and Surplus Lines segment, and in 2019, we experienced $69.0 million of adverse development on reserves for losses and loss adjustment expenses principally relating to the 2016 and 2017 accident years for the commercial auto business in our Excess and Surplus lines business. We cannot assure that we will not have further adverse development in this business.
The uncertainties we encounter in establishing our reserves for losses and related expenses in connection with our insurance businesses include:
•When we write “occurrence” policies, we are obligated to pay covered claims, up to the contractually agreed amount, for any covered loss that occurs while the policy is in force. Losses can emerge many years after a policy has lapsed. Accordingly, our first notice of a claim or group of claims may arise many years after a policy has lapsed. Approximately 94% of our Excess and Surplus Lines net casualty loss reserves are associated with “occurrence form” policies at December 31, 2020.
•Even when a claim is received (irrespective of whether the policy is a “claims made” or “occurrence” basis form), it may take considerable time to fully appreciate the extent of the covered loss suffered by the insured and, consequently, estimates of loss associated with specific claims can increase over time.
•New theories of liability are enforced retroactively from time to time by courts. See also “The effect of emerging claim and coverage issues on our business is uncertain” risk factor in our Annual Report on Form 10-K for the year ended December 31, 2020.
•Volatility in the financial markets, economic events and other external factors may result in an increase in the number of claims and the severity of the claims reported. In addition, elevated inflationary conditions could, among other things, cause loss costs to increase.
•If claims became more frequent, even if we had no liability for those claims, the cost of evaluating these potential claims could escalate beyond the amount of the reserves we have established. As we enter new lines of business, or as a result of new theories of claims, we may encounter an increase in claims frequency and greater claims handling costs than we had anticipated.
•We occasionally enter new lines of insurance, and as a consequence, we sometimes have to make estimates of future losses for risk classes with which we do not have a great deal of experience. This lack of experience may contribute to making errors of judgment when establishing reserves.
In addition, reinsurance reserve estimates are typically subject to greater uncertainty than insurance reserve estimates, primarily due to reliance on the original underwriting decisions made by the ceding company. As a result, we are subject to the risk that our ceding companies may not have adequately evaluated the risks reinsured by us and the premiums ceded may not adequately compensate us for the risks we assume. Other factors resulting in additional uncertainty in establishing reinsurance reserves include:
•The increased lapse of time from the occurrence of an event to the reporting of the claim and the ultimate resolution or settlement of the claim.
•The diversity of development patterns among different types of reinsurance treaties.
•The necessary reliance on the ceding company for information regarding claims.
If any of our insurance or reinsurance reserves should prove to be inadequate for the reasons discussed above, or for any other reason, we will be required to increase reserves, resulting in a reduction in our net income and shareholders’ equity in the period in which the deficiency is identified. Future loss experience substantially in excess of established reserves could also have a material adverse effect on future earnings and liquidity and financial rating, which could affect our ability to attract business, our cost of capital and our ability to retain or hire qualified personnel.
The ongoing effect of the 2017 Tax Act, as well as other changes in U.S. tax law, may have a significant impact on the Company.
Public Law No. 115-97, enacted in December 2017 and informally titled the Tax Cuts and Jobs Act (the “Tax Act”), introduced significant changes to the Internal Revenue Code of 1986, as amended. The Tax Act contained many provisions that impact us and our shareholders, including provisions that impose a base erosion and anti-abuse tax (“BEAT”) on income of a U.S. corporation determined without regard to certain otherwise deductible payments made to certain foreign affiliates (including premium or other consideration paid or accrued to a related foreign reinsurance company for reinsurance), broaden the definition of United States shareholder for purposes of the controlled foreign corporation rules, and make it more difficult for a foreign insurance company to avoid being treated as a passive foreign investment company (“PFIC”).
There is continued uncertainty regarding how these and other provisions of the Tax Act will be interpreted, although guidance in proposed and final forms has been released with respect to certain provisions of the Tax Act, including certain BEAT and PFIC provisions, that may impact the Company. The ultimate impact of the Tax Act may differ from the Company’s description below due to changes in interpretations, as well as additional regulatory guidance that may be issued. Given the
complexity of the Tax Act, you are strongly encouraged to consult your own tax advisor regarding its potential impact on the U.S. federal income tax consequences to you considering your particular circumstance.
Apart from enactment of the Tax Act, other legislative proposals or administrative or judicial developments could also result in an increase in the amount of U.S. tax payable by us or by an owner of our common shares.
We are subject to extensive regulation, which may materially adversely affect our ability to achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may materially adversely affect our financial condition and results of operations.
Our admitted insurance and reinsurance subsidiaries are subject to extensive regulation, primarily by California (the domiciliary state for Falls Lake Fire and Casualty Company), Ohio (the domiciliary state for James River Insurance and Falls Lake National), North Carolina (the domiciliary state for Stonewood Insurance), Virginia (the domiciliary state for James River Casualty), Bermuda (the domicile of JRG Re and Carolina Re), and to a lesser degree, the other jurisdictions in the United States in which we operate. Most insurance regulations are designed to protect the interests of insurance policyholders, as opposed to the interests of shareholders. These regulations generally are administered by a department of insurance in each state and, in the case of JRG Re and Carolina Re, the BMA in Bermuda, and relate to, among other things, authorizations to write certain lines of business, capital and surplus requirements, reserve requirements, rate and form approvals, investment and underwriting limitations, affiliate transactions, dividend limitations, cancellation and non-renewal of policies, changes in control, solvency, receipt of reinsurance credit, accounting principles and a variety of other financial and non-financial aspects of our business. These laws and regulations are regularly re-examined and any changes in these laws and regulations or new laws or interpretations thereof may be more restrictive, could make it more expensive to conduct business or otherwise materially adversely affect our financial condition or operations. State insurance departments and the BMA also conduct periodic examinations of the affairs of insurance companies and reinsurance companies and require the filing of annual and other reports relating to financial condition, holding company issues and other matters. These regulatory requirements may impose timing and expense or other constraints that could materially adversely affect our ability to achieve some or all of our business objectives. Failure by any of insurance subsidiaries to comply with applicable regulations could result in a requirement for that subsidiary to cease writing business.
In addition, regulatory authorities have broad discretion to deny or revoke licenses for various reasons, including the violation of regulations. For example, an insurer’s registration may be cancelled by the BMA on certain grounds specified in the Insurance Act, including failure by the insurer to comply with its obligations under the Insurance Act, or if the BMA believes that the insurer has not been carrying on business in accordance with sound insurance principles. In some instances, where there is uncertainty as to applicability, we follow practices based on our interpretations of regulations or practices that we believe are generally followed by the industry. These practices may turn out to be different from the interpretations of regulatory authorities. If we do not have the requisite licenses and approvals or do not comply with applicable regulatory requirements, insurance regulatory authorities could preclude or temporarily suspend us from carrying on some or all of our activities or otherwise penalize us. This could materially adversely affect our ability to operate our business.
The admitted market is subject to more state regulation than the E&S market, particularly with regard to rate and form filing requirements, restrictions on the ability to exit lines of business, premium tax payments and membership in various state associations, such as guaranty funds. Some states have deregulated their commercial insurance markets. We cannot predict the effect that further deregulation would have on our business, financial condition or results of operations.
The National Association of Insurance Commissioners (“NAIC”) has developed a system to test the adequacy of statutory capital of U.S.-based insurers, known as risk-based capital or “RBC,” that many states have adopted. This system establishes the minimum amount of risk-based capital necessary for an insurer to support its overall business operations. It identifies property-casualty insurers that may be inadequately capitalized by looking at certain inherent risks of each insurer’s assets and liabilities and its mix of net written premiums. Insurers falling below a calculated threshold may be subject to varying degrees of regulatory action, including supervision, rehabilitation or liquidation. Failure to maintain adequate risk-based capital at the required levels could materially adversely affect the ability of our insurance subsidiaries to maintain regulatory authority to conduct their business. For additional information, see “Item 1. Business—Regulation—U.S. Insurance Regulation—State Regulation.” in our Annual Report on Form 10-K for the year ended December 31, 2020, which report is incorporated into the prospectus supplement by reference.
In addition, the various state insurance regulators have increased their focus on risks within an insurer’s holding company system that may pose enterprise risk to the insurer. In 2012, the NAIC adopted certain amendments, which when adopted by the various states, are designed to respond to perceived gaps in the regulation of insurance holding company systems in the United States. One of the major changes is a requirement that an insurance holding company system’s ultimate controlling person submit annually to its lead state insurance regulator an “enterprise risk report” that identifies activities, circumstances or events involving one or more affiliates of an insurer that, if not remedied properly, are likely to have a material adverse effect upon the financial condition or liquidity of the insurer or its insurance holding company system as a whole. Other changes include (i) requiring a controlling person to submit prior notice to its domiciliary insurance regulator of a divestiture of control, (ii) having detailed minimum requirements for cost sharing and management agreements between an insurer and its affiliates and (iii) expanding the types of agreements between an insurer and its affiliates to be filed with its domiciliary insurance regulator. The amendments must be adopted by a state legislature and such state’s insurance regulator in order to be effective in that state. Each of California, North Carolina, Ohio and Virginia, the states in which our U.S. insurance subsidiaries are domiciled, include this enterprise risk report requirement.
In 2012, the NAIC also adopted the Risk Management and Own Risk and Solvency Assessment Model Act (the “ORSA Model Act”). The ORSA Model Act, when adopted by the various states, requires an insurance holding company system’s Chief Risk Officer to submit annually to its lead state insurance regulator an ORSA. The ORSA is a confidential internal assessment appropriate to the nature, scale and complexity of an insurer of the material and relevant risks identified by the insurer associated with an insurer’s current business plan and the sufficiency of capital resources to support those risks. The ORSA Model Act must be adopted by a state legislature in order to be effective in that state. Each of California, North Carolina, Ohio and Virginia, the states in which our U.S. insurance subsidiaries are domiciled, adopted and require an ORSA filing.
We cannot predict with certainty the effect any enacted, proposed or future state or federal regulation or NAIC initiative may have on the conduct of our business. Furthermore, there can be no assurance that the regulatory requirements applicable to our business will not become more stringent in the future or result in materially higher cost than current requirements. Changes in regulation of our business may materially reduce our profitability, limit our growth or otherwise materially adversely affect our operations.
We depend upon dividends and distributions from our subsidiaries, and we may be unable to distribute dividends to our shareholders to the extent we do not receive dividends from our subsidiaries.
We are a holding company that has no substantial operations of our own and, accordingly, we rely primarily on cash dividends or distributions from our operating subsidiaries to pay our operating expenses and any dividends that we may pay to shareholders. The payment of dividends by our insurance and reinsurance subsidiaries is limited under the laws and regulations of its applicable domicile. These regulations stipulate the maximum amount of annual dividends or other distributions available to shareholders without prior approval of the relevant regulatory authorities. As a result of such regulations, we may not be able to pay our operating expenses as they become due and our payment of future dividends to shareholders may be limited.
The payment of dividends by our subsidiaries to us is limited by statute. In general, the laws and regulations applicable to our U.S. insurance subsidiaries limit the aggregate amount of dividends or other distributions that they may declare or pay within any 12 month period without advance regulatory approval. In Ohio, the domiciliary state of Falls Lake National and James River Insurance, this limitation is the greater of statutory net income for the preceding calendar year or 10% of the statutory surplus at the end of the preceding calendar year, provided that such dividends may only be paid out of earned surplus of each of the companies, without obtaining regulatory approval. In North Carolina, the domiciliary state of Stonewood Insurance, this limitation is the greater of statutory net income excluding realized capital gains for the preceding calendar year or 10% of the statutory surplus at the end of the preceding calendar year, provided that such dividends may only be paid out of unassigned surplus without obtaining regulatory approval. In Virginia, the domiciliary state of James River Casualty, this limitation is the greater of statutory net income excluding realized capital gains for the preceding calendar year or 10% of the statutory surplus at the end of the preceding calendar year, provided that such dividends may only be paid out of unassigned surplus without obtaining regulatory approval. In California, the domiciliary state of Falls Lake Fire and Casualty Company, this limitation is the greater of statutory net income for the preceding calendar year or 10% of the statutory surplus at the end of the preceding calendar year, provided that such dividends may only be paid out of unassigned surplus without obtaining regulatory approval. In addition, insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels and could refuse to permit the payment of dividends calculated under any applicable formula. In addition, dividends paid by our U.S. subsidiaries to our U.K. holding company are subject to a 5% withholding tax by the IRS. Under U.K. domestic law, no withholding tax is applied to dividends paid by U.K. tax resident companies.
Carolina Re and JRG Re, which are domiciled in Bermuda, are registered as a Class 3A and Class 3B, respectively, insurer under the Insurance Act. The Insurance Act, the conditions listed in the insurance license and the applicable approvals issued by the BMA provide that Carolina Re and JRG Re are required to maintain a combined minimum statutory solvency margin of approximately $172.9 million as of December 31, 2020. A Class 3A and a Class 3B insurer is prohibited from declaring or paying a dividend if it fails to meet, before or after declaration or payment of such dividend, its: (i) requirements under the Companies Act, (ii) minimum solvency margin, (iii) enhanced capital requirement or (iv) minimum liquidity ratio. If a Class 3A or Class 3B insurer fails to meet its minimum solvency margin or minimum liquidity ratio on the last day of any financial year, it is prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA. In addition, Carolina Re, as a Class 3A insurer, and JRG Re, as a Class 3B insurer, is prohibited from declaring or paying in any financial year dividends of more than 25% of its total statutory capital and surplus (as shown on its previous financial year’s statutory balance sheet) unless it files (at least seven days before payment of such dividends) with the BMA an affidavit signed by at least two directors (one of whom must be a Bermuda resident director if any of the insurer’s directors are resident in Bermuda) and the principal representative stating that it will continue to meet its solvency margin and minimum liquidity ratio. Where such an affidavit is filed, it shall be available for public inspection at the offices of the BMA.
The inability of our subsidiaries to pay dividends or make distributions to us, including as a result of regulatory or other restrictions, may prevent us from paying our expenses or paying dividends to our shareholders.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other information
The Company intends to hold the 2021 annual general meeting of shareholders (the “2021 Annual Meeting”) on October 26, 2021. The record date, time and location of the 2021 Annual Meeting will be set forth in the proxy statement for the 2021 Annual Meeting to be distributed to shareholders prior to the meeting.
The date of the 2021 Annual Meeting represents a change of more than 30 days from the anniversary date of the Company’s 2020 annual general meeting of shareholders (the “2020 Annual Meeting”). As a result, the deadlines for shareholder proposals set forth in our definitive proxy statement for the 2020 Annual Meeting are no longer effective. Shareholder proposals intended for inclusion in the Company’s definitive proxy statement for the 2021 Annual Meeting pursuant to Rule 14a-8 of the Exchange Act must be received by August 17, 2021 (which the Company believes is a reasonable time before it begins to print and send its proxy materials). Any such shareholder proposal should be sent to our registered office c/o Conyers Corporate Services (Bermuda) Limited, Clarendon House, P.O. Box HM 1022, Hamilton HM DX, Bermuda. Any such proposal must comply with the requirements of Rule 14a-8.
In accordance with the Company’s Third Amended and Restated Bye-laws (the “Bye-laws”), shareholders who intend to nominate a person for election as a director or submit a proposal regarding any other matter of business at the 2021 Annual Meeting must deliver written notice of the shareholder’s intention to do so, which notice must include the information required by the Bye-laws. To be timely, the shareholder’s notice must be delivered to or mailed and received by the Company’s Secretary at the registered office of the Company identified above no earlier than June 28, 2021 and no later than August 17, 2021.
Item 6. Exhibits
| | | | | | | | |
Exhibit Number | | Description |
3.1 | | |
| | |
3.2 | | |
| | |
3.3 | | |
| | |
3.4 | | |
| | |
3.5 | | |
| | |
3.6 | | |
| | |
31.1 | | |
| | |
31.2 | | |
| | |
32 | | |
| | |
101.INS | | Inline XBRL Instance Document |
| | |
101.SCH | | Inline XBRL Taxonomy Extension Schema Document |
| | |
101.CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| | |
101.DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| | |
101.LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document |
| | |
101.PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| | |
104 | | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document in Exhibit 101. |
| | |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | | | | |
| | James River Group Holdings, Ltd. |
| | | |
Date: | May 5, 2021 | By: | /s/ Frank N. D'Orazio |
| | | Frank N. D'Orazio |
| | | Chief Executive Officer and Director |
| | | (Principal Executive Officer) |
| | | |
Date: | May 5, 2021 | By: | /s/ Sarah C. Doran |
| | | Sarah C. Doran |
| | | Chief Financial Officer |
| | | (Principal Financial Officer) |